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Mammalian constitutive photomorphogenic 1 (COP1), a p53 E3 ubiquitin ligase, is a key
negative regulator for p53. DNA damage leads to the translocation of COP1 to the
cytoplasm, but the underlying mechanism remains unknown. We discovered that 14-3-3σ
controlled COP1 subcellular localization and protein stability. Investigation of the
underlying mechanism suggested that, upon DNA damage, 14-3-3σ bound to
phosphorylated COP1 at S387, resulting in COP1 translocation to the cytoplasm and
cytoplasmic COP1 ubiquitination and proteasomal degradation. 14-3-3σ targeted COP1 for
degradation to prevent COP1-mediated p53 degradation, p53 ubiquitination, and p53
transcription repression. COP1 expression promoted cell proliferation, cell transformation,
and tumor progression, attesting to its role in cancer promotion. 14-3-3σ negatively
regulated COP1 function and prevented tumor growth in cancer xenografts. COP1 protein
levels were inversely correlated with 14-3-3σ protein levels in human breast and pancreatic
cancer specimens. Together, these results define a novel, detailed mechanism for the
posttranslational regulation of COP1 upon DNA damage and provide a mechanistic
v

explanation of the correlation of COP1 overexpression with 14-3-3σ downregulation during
tumorigenesis.
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CHAPTER 1. INTRODUCTION

1.1 Introduction of 14-3-3 proteins
The 14-3-3 proteins (28 – 33 kDa) were originally isolated as acidic, abundant bovine brain
proteins (Moore and McGregor, 1965). 14-3-3 proteins are found in all eukaryotic
organisms, including humans, Xenopus, Drosophila, and yeast, (Boston and Jackson, 1980;
Martens et al., 1992; Skoulakis and Davis, 1996; van Heusden et al., 1995) and in plant
species (Aitken et al., 1992). The mammalian 14-3-3 proteins consist of seven isoforms (β,
ε, γ, ζ, η, σ, and τ) and their isoforms have 75%-92% sequence identity (Broadie et al.,
1997). According to alignments of 11 human, budding yeast, and fission yeast 14-3-3
proteins, a phylogenetic analysis of these sequences shows that 14-3-3σ is the most
divergent compared with the rest of 14-3-3 proteins in Figure 1-1. It has been known that
14-3-3 proteins can form homo- and heterodimers and bind to their targets through an
amphipathic binding cleft (Jones et al., 1995; Tzivion et al., 1998). 14-3-3 proteins
preferentially recognize the consensus phosphorylated binding motifs RSX (pS/T) XP and
RXXX(pS/T)XP in their targets (Rittinger et al., 1999; Yaffe et al., 1997). These motifs are
highly conserved among 14-3-3 proteins, which indicate that the 14-3-3 proteins are
functionally redundant. Although the majority of 14-3-3 targets contain these consensus
phosphorylated binding motifs, some of the more well-known 14-3-3 targets, such as IGF-1
receptor (Furlanetto et al., 1997) and Wee1 (Honda et al., 1997a; Wang et al., 2000), do not.
Moreover, the 14-3-3 monomer has also been found to recognize targets, such as Raf
(Tzivion et al., 1998), while Raf activity is different in 14-3-3 monomer binding compared
to 14-3-3 dimer binding. In these cases, the binding is mediated by the conserved
1

amphipathic cleft which is present in all of 14-3-3 proteins (Henriksson et al., 2002; Zhang
et al., 1997).

Due to the broad range of target proteins, 14-3-3 proteins are involved in many biological
activities, including: apoptosis, cell cycle regulation, DNA damage, transcription, etc
(Takahashi, 2003). There are five modes of action which explain how the 14-3-3 isoforms
exert their functions on regulating their targets (Bridges and Moorhead, 2005). These modes
of action include: (i) 14-3-3 proteins binding to their targets which subsequently change the
ability of the targets to interact with other proteins. An example of such interaction involves
nonphosphorylated BAD, a proapoptotic protein, and its association with Bcl-2/Bcl-xl, an
anti-apoptotic protein. The Bcl-2 homology 3 (BH3) domain of BAD binds to Bcl-2/Bcl-xl
to inhibit Bcl-2/Bcl-xl’s the anti-apoptotic function. However, AKT phosphorylation of
BAD at Ser-155 causes 14-3-3 to competitively bind against Bcl-2. This releases Bcl-2,
which in turn allows it to utilize its anti-apoptotic effects (Datta et al., 2000; Hsu et al.,
1997; Zha et al., 1996). (ii) 14-3-3 binding altering the subcellular localization of targets.
For example, the phoshatase CDC25C dephosphorylates CDC2 at Thr-14 and Thr-15, which
results in CDC2 activation for initiating mitotic entry (Gautier et al., 1991). When CHK1
phosphorylates CDC25C, 14-3-3 binds to phosphorylated form of CDC25C, thereby leading
to cytoplasmic sequestration. This causes to increased CDC2 phosphorylation which inhibits
the entry in mitosis (Graves et al., 2001; Sanchez et al., 1997). (iii) 14-3-3 binding
preventing targets from receiving additional modification such as proteolysis and
dephosphorylation (Chiang et al., 2001; Dent et al., 1995). This is observed during 14-3-3
binding to Arabidopsis cytosolic enzymes which have functions in protein synthesis and
2

carbon and nitrogen assimilation. When 14-3-3 binding is lost, the cytosolic proteins are
cleaved into proteolytic fragments (Cotelle et al., 2000). (iv) 14-3-3 binding changing the
transcriptional or catalytic activity of targets (Thorson et al., 1998; Tzivion et al., 1998).
When phosphorylated p53 in Ser 378 binds to 14-3-3 after DNA damage, this leads to an
increased binding affinity of p53 to its DNA sequence (Waterman et al., 1998). (v) 14-3-3
dimer binding two different proteins together. It has been demonstrated that 14-3-3 uses its
N-terminus for dimerization. Whereas 14-3-3 uses it’s C-terminus for target binding. In
these cases, one C-terminal arms can binds to one protein and the other one can bind to the
other protein. Thus, both targets will be spatially constrained, and downstream effect of
these complexes will be increased. This can be observed in Bcr-Raf and PKCζ-Raf
(Braselmann and McCormick, 1995; Bridges and Moorhead, 2005; Van Der Hoeven et al.,
2000). Taken together, these five modes of action are responsible for 14-3-3 targets’
specificity.

3

Figure 1-1. 14-3-3 family cladogram. A rooted phylogenetic tree of the sequences is
generated among human 14-3-3 (YWHAZ, 14-3-3zeta; YWHAG, 14-3-3gamma; YWHAH,
14-3-3eta; YWHAQ, 14-3-3theta; SFN, 14-3-3sigma; YWHAB, 14-3-3beta; YWHAB, 143-3epsilon), budding yeast Rad25 and Rad24, fission yeast BMH1 and BMH2 using
ClustalW2 program. This reveals that 14-3-3σ is evolutionarily distinct from all other 14-3-3
isoforms.

4

1.2 Introduction of 14-3-3σ
14-3-3σ, also called HME1, was originally isolated in human mammary epithelial cells, and
was downregulated during neoplastic transformation (Prasad et al., 1992). 14-3-3σ is also
known as SFN (stratifin) due to its expression in epithelial cells, especially within stratified
epithelia. There are several evidence that show that 14-3-3σ has unique functions in
comparison to other isoforms (Leffers et al., 1993). The evidence includes: (i) 14-3-3σ has
two unique residues, Ser 5 and Glu 80, that lie opposite to each other at the interface,
whereas, other 14-3-3 isoforms have Asp 5 or Glu 5 residues. When the σ isoform forms the
heterodimer with other isoforms, the structure is highly unstable between positions 5 and 80,
supporting that 14-3-3σ preferentially forms homodimers (Wilker et al., 2005). (ii) 14-3-3σ
has three unique residues (Met 202, Asp 204, and His 206) that allow the σ isoform to bind
to particular targets that are not recognized by other 14-3-3 proteins (Wilker et al., 2005).
(iii) 14-3-3σ located in chromosome 1p35 is a direct target of the transcriptional factor p53
and is induced by tumor suppressor p53 upon DNA damage (Hermeking et al., 1997). It also
binds to and activates p53 in a positive feedback loop (Yang et al., 2007). (iv) 14-3-3σ can
sequester CDC2-cyclin B to the cytoplasm which results in G2 arrest following DNA
damage (Chan et al., 1999; Laronga et al., 2000). (v) 14-3-3σ is the only isoform directly
linked to tumorigenesis, in that 14-3-3σ expression is hypermethylated at high frequency in
carcinomas of the breast, prostate, liver, lung, skin, and ovaries (Benzinger et al., 2005;
Ferguson et al., 2000; Iwata et al., 2000; Lodygin et al., 2004; Lodygin et al., 2003;
Mhawech et al., 2005; Osada et al., 2002).

(vi) 14-3-3σ silencing in cells causes

chromosome aberrations such as DNA double strand breaks, aneuploidy, nonreciprocal
5

translocations and end-to-end fusion. This increases to genomic instability, suggesting that
14-3-3σ plays an important role in maintaining genomic integrity (Dhar et al., 2000). In
summary, 14-3-3σ has critical residues that are not found in other isoforms. These lead to a
unique structure and function of 14-3-3σ. 14-3-3σ is the only isoform that functions as a
tumor suppressor and is silenced in cancer. Therefore, it is interesting to identify the
possible regulators in silencing 14-3-3σ during tumorigenesis.

1.3 The E3 ligase EFP for 14-3-3σ
In addition to epigenetic silencing of 14-3-3σ, it has been shown that 14-3-3σ is
ubiquitinated by estrogen-response finger protein (EFP). EFP has been isolated as an
estrogen-response gene by the genomic binding site cloning method (Inoue et al., 1993).
EFP contains RING-finger, B-box, and SPRY domains (Inoue et al., 1993). The RINGfinger has E3 ligase activity, while B-box allows for zinc binding. SPRY domain mediates
protein-protein interactions. The efp gene contains an estrogen-responsive element (ERE) at
the 3’-untranslated region (Orimo et al., 1995; Thomson et al., 2001). In addition to ERE,
the levels of EFP is regulated by upstream stimulatory factor-1 (USF-1), which can bind to
the E-box in the promoter region of EFP (Ikeda et al., 1997; Ikeda et al., 1998). Previous
findings show that estrogen responses are markedly reduced in the uterus of EFP-deficient
mice, supporting that EFP is essential for estrogen-induced cell growth (Orimo et al., 1999).
In contrast, EFP-overexpressing MCF7 cells generate tumors independent of estrogen levels.
EFP is thought to promote breast cancer by functioning as E3 ligase on 14-3-3σ.
Conversely, the loss of EFP has shown to cause the accumulation of 14-3-3σ in EFP
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knockout MEF cells (Urano et al., 2002). Given that EFP is expressed in the uterus, ovary,
brain, placenta, and mammary glands, and that 14-3-3σ is deregulated in cancers (Orimo et
al., 1995), it remains to be seen if EFP may be required for the deregulation of 14-3-3σ in
these tissues during tumorigenesis.

1.4 14-3-3σ regulations on p53 in a positive feedback loop in response to DNA damage
As mentioned in section 1.2, 14-3-3σ, a p53 target gene, is induced by p53 in response to
DNA damage (Hermeking et al., 1997). 14-3-3σ functions is a negative regulator of cyclindependent kinase (CDK). For example, cdc2-cyclinB, responsible for G2-M transition, is
accumulated in the nucleus. However, 14-3-3σ sequesters this complex to the cytoplasm,
which causes G2 arrest (Chan et al., 1999; Samuel et al., 2001). Moreover, it has been
shown that 14-3-3σ is associated with cyclin-CDK2. Ectopic expression of 14-3-3σ inhibits
cyclin-Cdk2 activity and inhibits cell proliferation in breast cancer cell lines (Laronga et al.,
2000). Thus it is shown that 14-3-3σ, like p53, has a role in negatively regulating cell cycle
progression, which further suggests that 14-3-3σ functions as a tumor suppressor and has a
possible linkage on p53. An example of 14-3-3σ’s tumor suppressor function involves its
role in p53 tetramerization which is critical for both p53 binding to DNA sequence and
facilitating p53 transcriptional activity (Waterman et al., 1998). It has been shown that 14-33σ facilitates p53 dimer-dimer interactions, which stabilizes p53 binding to DNA, and
enhances p53 transcriptional activity. In addition to tetramer formation, 14-3-3σ has been
shown to negatively regulate the p53-interacting protein: MDM2 (Yang et al., 2003; Yang et
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al., 2007). Thus it is observed that 14-3-3σ positively regulates p53 proteins through
stabilizing p53 and increasing p53 transcriptional activity.

1.5 14-3-3σ negative regulation on a p53 E3 ligase MDM2
MDM2 (murine double minute 2) is an ubiquitin ligase and located at position 12q13. mdm2
gene is amplified in many cancers and MDM2 is overexpressed in many types of cancers in
which gene is not amplified (Freedman et al., 1999; Momand et al., 1998; Oliner et al.,
1992). MDM2 contains a RING-finger domain at the C-terminus and a p53-binding domain
at the N-terminus, suggesting that MDM2 functions as E3 ligases. It has been known that
MDM2 is a major E3 ubiquitin ligase for p53 (Haupt et al., 1997; Honda et al., 1997b;
Kubbutat et al., 1997). It binds to and ubiquitinates p53. Studies have shown that the
expression level of p53 is increased in the presence of 14-3-3σ. Mechanistically, ectopic 143-3σ expression increases the steady state and half-life of p53. In this case, an increasing
level of 14-3-3σ results in shortening the half-life of MDM2. These observations indicate
14-3-3σ stabilizes p53 by downregulating MDM2. At the same time, 14-3-3σ blocks
MDM2-mediated p53 ubiquitination (Yang et al., 2003).

MDM2 contains both nuclear localization signal (NLS) and nuclear export signal (NES),
supporting that MDM2 is moved between the cytoplasm and nucleus (Deb, 2002). It is
known that MDM2 binds to p53 and promotes p53 nuclear export, which can be inhibited by
14-3-3σ (Boyd et al., 2000; Chen et al., 1993; Geyer et al., 2000). 14-3-3σ blocks MDM2mediated nuclear export, thereby stabilizing and retaining p53 in the nucleus (Yang et al.,
2007).
8

In summary, 14-3-3σ positively regulates p53 by: (i) 14-3-3σ binds to and promotes p53
oligomerization, thereby enhancing p53 transcriptional activity. (ii) 14-3-3σ blocks MDM2mediated p53 nuclear export and degradation. However, it is interesting to explore further
how 14-3-3σ regulates other p53-interacting proteins and protect p53 from degradation. This
regulation eventually leads to proper cell cycle and genomic integrity.

1.6 The discovery of COP1 and its role in Arabidopsis
COP1

(constitutive

photomorphogenic

1)

is

first

identified

in

Arabidopsis

photomorphogenesis using a genetic screen. Dr. Deng shows that cop1 mutant seedlings
have light-grown morphology even when it is grown in the dark, suggesting that COP1
functions as a repressor of light-induced genes and negatively regulates photomorphogenesis
in the dark (Deng et al., 1991). Later on a genetic analysis has identified a set of genes that
suppress

photomorphogenesis,

consisting

of

11

pleiotropic

de-etiolated

(DET),

constitutively photomorphogenic (COP), or fusca (FUS) loci in Arabidopsis (Wei et al.,
1994). Among them, det1, cop1, cop8, cop9, cop10, and cop11 mutant display light-grown
phenotypes in the dark (Castle and Meinke, 1994; McNellis et al., 1994; Misera et al., 1994).
However, the rest of genes, including cop2, cop3, cop4, det2, and det3, only play a minor
effect in seedling development. During this early period, they show that Arabidopsis COP9
is a component of the huge (550 kDa – 600 kDa) complex and COP8 and COP11 are
involved in the formation or stability of COP9 complexes (Wei et al., 1994). Arabidopsis
COP8, COP9, COP11 are known as CSN4, CSN8, and CSN1, respectively in mammals
(Serino et al., 1999; Wei and Deng, 1998, 1999; Wei et al., 1998).
9

Arabidopsis COP1 has 51 % identity in the RING-finger and the WD40 repeat domains
compared to mouse COP1 (Wang et al., 1999) and mouse COP1 and mammalian COP1
protein share around 97% identity (Yi et al., 2002). This indicates that functions and
regulations of COP1 may be conserved in animals and plants. Arabidopsis COP1 contains
three highly conserved domains: RING-finger, coiled-coil domain, and seven WD40 repeats,
suggesting that COP1 has E3 ligase activity. The Arabidopsis COP1 nuclear localization
signal (NLS) is located immediately upstream of the WD40 repeats. Two of Arabidopsis
COP1 nuclear export signals (NES) are located in RING-finger and coiled-coil domain
(Holm and Deng, 1999). Arabidopsis COP1 displays light-mediated shuttling between the
cytoplasm and nucleus, supporting the notion that localization of COP1 is critical for COP1
activity and functions. For example, COP1 is located in the cytoplasm in the light but
translocates to the nucleus in the dark where it degrades HY5, a light-induced transcription
factor (Hardtke et al., 2000; Osterlund et al., 2000). Thus the light in plant triggers COP1
nuclear–cytoplasmic repartitioning.

1.7 Introduction of mammalian COP1
COP1 is also known as RFWD2, ring finger and WD repeat domain 2. COP1 has three
isoforms generated by alternative splicing of COP1 pre-mRNA. In addition to full length of
COP1 (731 kDa, around 90 kDa), COPΔ24 lacks the four terminal amino acids in exon 4
and all 20 amino acids in exon 7 (707 kDa, less than 90 kDa). The other is COP1ΔRING +
cc, which lack all the RING-finger and part of coiled-coil domain (506 AA, 50-60 kDa)
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(Wertz et al., 2004). The physiological roles of COP1 isoforms would certainly be of interest
to study in the future.

COP1 is an E3 ligase and degrades tumor suppressor p53, hinting that COP1 plays a
negative role in cell cycle arrest and apoptosis (Dornan et al., 2004a). However, roles of
COP1 are poorly understood in cancer although previous studies have shown that COP1 is
widely expressed in normal human issues, including human testes, thymus, tonsil, pancreas,
colon, heart, prostate, spleen, intestine, and live (Bianchi et al., 2003; Dornan et al., 2004a).
Thus it would be of interest to examine further what role COP1 deregulation and COP1
regulatory pathways play in these types of tumors. In concordance of COP1 localization in
1q25.1-1q25.2, it could be further addressed whether cop1 gene is amplified in these types
of cancer.

1.8 Substrates of COP1 E3 ligase
Mammalian COP1 ring-finger and WD40 repeats share 51 % identity in these domains of
Arabidopsis COP1. It indicates that COP1’s E3 ligase function is conserved and that target
similarity is high between organisms. For example, Arabidopsis COP1 degrades HY5 and
HYH, which are basic-leucine zipper (bZIP) transcription factors, and mammalian COP1,
functions as an adaptor, directly binds to the bZIP transcription factor c-Jun. c-Jun is
ubiquitinated by CUL4-associated complex, including DDB1, DET1, and COP1 (Wertz et
al., 2004). While attempting to identify the physiological roles of mammalian COP1, an
ever-increasing number of mammalian COP1 E3 ligase substrates are being identified. Some
examples include COP1 reportedly binding and ubiquitinating apoptosis-inducing
11

transcriptional factor FOXO1 and stress-response transcriptional factor p53 (Dornan et al.,
2004a; Kato et al., 2008). This reveals that COP1 has negative impact on cell cycle arrest.
COP1 is also shown to play a role in lipid metabolism by regulating the stability of acetylcoenzyme A carboxylase (ACC) through interaction with pseudokinase Tribble 3 (TRB3).
Moreover, COP1 plays a role in insulin-modulated gluconeogenesis by regulating the
stability of cAMP-response CREB coactivator TORC2 (Dentin et al., 2007; Qi et al., 2006).
Moreover, COP1 also plays a role in metastasis by regulating the stability of the
transcriptional factor ERM in the presence of DET1 (Baert et al., 2010). Domains and
substrates of COP1 are shown in Figure 1-2. 1The COP1 binding motif has been recently
reported as DD (EE)-XX-VP (Dentin et al., 2007). Analysis of amino acid sequences of
COP1 E3 ligase substrates reveals that c-JUN, DDB1, TRB3, TORC2, and ERM all contains
the COP1 consensus binding motif. This is suggestive that substrates of COP1 can be
identified through the COP1 binding motif in the future.
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Figure 2-1. Domains and substrates of mammalian COP1. COP1 has RING-finger, coiled coil, and seven WD40
repeats (WD1, 419-458 residues; WD2, 468-508 residues; WD3, 511-551 residues; WD4, 553-593 residues;
WD5, 597-635 residues; WD6, 638-677 residues; WD7, 691-729 residues). COP1 also contains nuclear
localization signal and nuclear export signal. FOXO1 and c-Jun binds to WD40 repeats of COP1. 14-3-3σ and
ERM binds to coiled-coil region of COP1.

1.9 COP1 upstream regulators: COP9 signalosome
COP9 signalosome is a conserved protein complex in plants and animals. It consists of eight
distinct subunits spanning molecular weights from 57 kDa to 22 kDa (Wei and Deng, 1998;
Wei et al., 1998). Like COP1, it plays a negative role in Arabidopsis seedling development.
It has been shown that COP9 is required for nuclear accumulation of COP1 in the dark;
COP1 normally locates in the cytoplasm in the light but translocates to the nucleus in the
dark (von Arnim and Deng, 1994). However, in cop9 and other cop/det/fus mutant, COP1
can not be found in the nucleus in the dark (Chamovitz et al., 1996; Schwechheimer and
Deng, 2000). There are two potential mechanisms to explain this phenomenon. First is that
the COP9 signalosome may be directly involved in nuclear import of COP1. In addition, the
COP9 signalosome may be indirectly involved in nuclear import of COP1 through removal
of COP1 binding partners that drives COP1 into the cytoplasm. The second mechanism
could be that the COP9 signalosome may be protecting COP1 from degradation in the
nucleus. In any event, these mechanisms indicate that the COP9 signalosome is a COP1
upstream effector, which in turn regulates COP1’s functions. In mammals, it has been
shown that MLF1, myeloid leukemia factor 1, collaborates with CSN3 to induce G1 arrest in
a p53-dependent manner through inhibition of COP1-mediated p53 instability (Yoneda-Kato
et al., 2005). This is the first time to show CSN3-COP1 regulations in mammalian cells. In
DNA damage pathway, it has been observed that CSN3 is phosphorylated and recognized by
ATM (Ataxia telangiectasia, mutated) in response to DNA damage through the use of largescale screens. More specifically this phosphorylated CSN3 is located on DNA double strand
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breaks (Matsuoka et al., 2007; Shiloh, 2006). It is also observed that the ubiquitination
processes of repair proteins, such as DDB1 and DDB2, and Cdt1, are regulated by COP9
signalosome. COP1 is also phosphorylated by ATM following DNA damage (Groisman et
al., 2003; Higa et al., 2003). These suggest that roles of COP1 in DNA damage and DNA
repair may be regulated by its upstream effecter, COP9 signalosome.

1.10

The role of COP1 in response to DNA damage

As mention above, COP1 is a p53 E3 ligase and promotes p53 degradation through
ubiquitination. It is conceivable that the inhibition of p53 E3 ligases is an important step for
p53 stabilization after DNA damage. The steady-state levels of COP1 are reduced which is
dependent on ATM in response to ionizing radiation (Dornan et al., 2006). ATM is the key
regulators in DNA damage checkpoint pathways (Ljungman and Lane, 2004; Yang et al.,
2004). For example, ATM directly phosphorylates p53 on Ser 15, leading to the stabilization
of p53 and to the increase in transcriptional activity of apoptosis and cell cycle checkpoint
genes (Banin et al., 1998; Canman et al., 1998; Nakagawa et al., 1999). ATM-activated
CHK2 phosphorylates p53 on Ser 20, thereby preventing binding between MDM2 and p53,
thus p53 levels are accumulated after DNA damage (Chehab et al., 2000; Chehab et al.,
1999; Hirao et al., 2000). Because of this, it is thought that ubiquitination of p53 is blocked
in a ATM-dependent manner in response to DNA damage. Another example of indirect
ATM regulations of p53 is COP1. Ectopic COP1 levels are reduced in the presence of ATM
but not ATM-kinase dead mutant. ATM phosphorylates COP1 at Ser 387 and
phosphorylated COP1 at Ser 387 reduces the binding between COP1 and p53, which in turn
causes p53 stabilization after DNA damage. This also results in the phosphorylated COP1
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being autoubiquitination (Dornan et al., 2006). In summary, COP1 loses its binding affinity
for p53 once it is phosphorylated by ATM in response to DNA damage

The turnover of endogenous COP1 was decreased in CSN3-knockdown cells compared to
when NIH3T3 cells are treated with ultraviolet light (UV, 25 J/m2). Indicating that CSN3 is
involved in the instability of COP1 although currently the details of this are unknown.
Furthermore, UV-induced COP1 degradation occurs in human keratinocytes. These
observations indicate that levels of COP1 are regulated in normal and cancer cells by DNA
damage agents. Altogether the evidence indicates that the functions of COP1 are important
in cell signaling.

1.11

The role of COP1 in cancer

On the basis that COP1 is a p53 E3 ligase it can be assumed that COP1 negatively regulates
cell cycle pregression and may play a role in tumor progression. It has been reported that
COP1 is overexpressed in ovarian adenocarcinoma using a tissue microarray (Dornan et al.,
2004a). COP1 overexpressed samples show decreased p21 mRNA levels, which are p53
wild-type. This could indicate that COP1 overexpression in ovarian cancer is in p53dependent manner through degrading tumor suppressor p53 and further reducing p53
transcriptional activity. In breast adenocarcinomas, COP1 is overexpressed in 67% of cases.
When the levels of wild-type p53 are reduced, COP1 is found overexpressed. Recent studies
show that COP1 is overexpressed in hepatocellular carcinoma (HCC), the third most lethal
neoplasm in the world (Lee et al. 2010). Taken together, COP1 is overexpressed in breast
cancer, ovarian cancer and hepatocellular carcinoma. It suggests that COP1 play a role in
16

tumor progression through inhibiting the functions of wild-type p53. Due to its roles in
tumorigenesis, COP1 deregulation and signaling in many other types of cancer will be
further addressed.

1.12

Rationale and hypothesis

In this study we investigate whether the tumor suppressor 14-3-3σ negatively regulates
COP1 through the use of COP1 nuclear export and manipulation of COP1 stability. It has
been reported that COP1 is an E3 ligase of the tumor suppressor p53. Moreover, COP1
knockdown by siRNA sensitizes U2OS cells, a p53 wild-type cell line, to p53-induced cell
death in response to ionizing radiation. It indicates that COP1 may promote cell growth and
tumor formation through inhibiting the functions of p53. 14-3-3σ, a p53 target gene, is
induced in response to DNA damage. 14-3-3σ induction causes G2 arrest because it inhibits
the activities of cyclin-dependent kinases (CDK), suggesting that 14-3-3σ tightly controls
the activity of cell cycle checkpoints. However 14-3-3σ silencing cells causes mitotic
catastrophe following DNA damage. This indicates that 14-3-3σ plays a positive role in the
levels of p53 and functions as a tumor suppressor gene. According to the above
observations, we hypothesize that 14-3-3σ negatively regulates COP1, and this interplay
between 14-3-3σ and COP1 prevents COP1-mediated p53 instability. Moreover the negative
impact of COP1 on p53 may translate to COP1-mediated cell cycle progression and tumor
formation, which may be abolished by 14-3-3σ. First, we detect whether or not 14-3-3σ
affects COP1 localization in response to DNA damage. Second, COP1 stability is addressed
in the presence of 14-3-3σ compared to the absence of 14-3-3σ. Third, we examine whether
COP1 promotes cell proliferation, cell transformation and tumor progression. Lastly, to
17

address the biological significance of this study, we measure whether 14-3-3σ blocks the
biological functions of COP1 and 14-3-3σ prevents COP1-mediated p53 ubiquitination and
degradation and COP1-mediated cell proliferation and tumor progression.
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CHAPTER 2. MATERIALS AND METHODS

2.1 Cell culture and reagents
Human 293T, A549, and H1299 are obtained from American Type Culture Collection
(ATCC). MEF (p53−/−, MDM2−/−) are generously provided by Guillermina Lozano’s
laboratory, AT22IJE-T/pEBS7 (ATM−/−), AT22IJE-T/YZ5 (ATM+/+) cells were maintained
in DMEM/F12 medium supplemented with 10% fetal bovine serum, 100 U/ml Penicillin,
and 100 µg/ml streptomycin at 37 °C in 5% CO2. AT22IJE-T cells (ATM−/− fibroblasts) and
AT22IJE-TpEBS7-YZ5 cells (ATM−/− fibroblasts complemented with ATM cDNA) were
generously provided by Dr. Y. Shiloh’s laboratory (Tel Aviv University, Tel Aviv, Israel).
HCT116 14-3-3σ−/−, HCT116 14-3-3σ +/+ cells and U2OS cells were cultured in McCoy’s 5A
medium supplemented with 10% FBS and antibiotics. HCT116 14-3-3σ−/−, HCT116 14-3-3σ
+/+

cells were provided by Dr. Bert Vogelstein. For transient transfection, cells were

transfected with DNA by either FuGENE® HD, or Lipofectamine™ 2000 reagents
according to protocols by the manufacturers.

2.2 Antibodies and reagents
Table 1 shows the list of antibodies and Table 2 shows the list of reagents.
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Table 2-1. List of antibodies.
Antibody

Clone #

Manufacturer

Description

S

Catalog #

1433S01

RDI (MA, USA)

M

1433Sabm

p53

FL-393

Santa Cruz (CA, USA)

amino acids 1-393

R

sc-6243

p53

DO-1

Santa Cruz (CA, USA)

amino acids 11-25

M

sc-126

COP1

Bethyl Lab. (TX, USA)

amino acids 1-50

R

A300-894A

Flag

Sigma (MI, USA)

Flag peptide

M

F1804

GST specific domain

M

sc-138

GST

B-14

Santa Cruz (CA, USA)

HA

12CA5

Roche (IN, USA)

M

583816001

Cell Signaling (CA, USA) 6xHis epitope

R

2365

Millipore (MA, USA)

R

05-636

R

ab16048

R

C3956

M

sc-40

M

T5168

M

sc-8017

His
γ−H2AX

JBW301

Lamin B1

Abcam (MA, USA)

Myc

Sigma (MI, USA)

400-500 of Lamin B1

Myc

9E-10

Santa Cruz (CA, USA)

α−Tubulin

B-5-1-2

Sigma (MI, USA)

Ubiquitin

P4D1

Santa Cruz (CA, USA)

amino acids 408-439

amino acids 1-76

Alexa Fluor
488

Molecular Probes (CA)

R

A11034

568

Molecular Probes (CA)

M

A11031

Thermo scientific (CA)

M

31437

Thermo scientific (CA)

R

31463

eBioscience (CA, USA)

M

18-8817-33

eBioscience (CA, USA)

R

18-8816-33

ImmunoPure Antibody

TrueBlot Antibody
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Table 2-2. List of reagents.
Reagent

Manufacturer

Catalog #

M2 beads

Santa Cruz (CA, USA)

A2220

G-418 disulfate salt

Sigma (MI, USA)

A1720

Puromycin

Invivogen (CA, USA)

ant-pr-5

Blasticidin

Invivogen (CA, USA)

ant-bl-1

MTT

Sigma (MI, USA)

M5655

L-Glutathione reduced

Sigma (MI, USA)

G4251

SYBR Green Supermix

Bio-Rad (CA, USA)

170-8882

cDNA synthesis Kit

Bio-Rad (CA, USA)

170-8891

DAPI

Sigma (MI, USA)

D9542

Flag-peptide

Sigma (MI, USA)

F3290

E1

Boston Biochem (MA)

E-305

E2

Boston Biochem (MA)

E2-622

Ubiquitin

Boston Biochem (MA)

U530

Doxorubicin

Sigma (MI, USA)

44583

FuGENE® HD

Roche (IN, USA)

4709691001

Lipofectamine™ 2000

Invitrogen (CA, USA)

11668019

MG132

Sigma (MI, USA)

C2211

ECL

Milipore (MA, USA)

WBLUR0100

N-Ethylmaleimide

Sigma (MI, USA)

E1271

Dual luciferase assay system

Promega (WI, USA)

E1960

Propidium Iodide

Sigma (MI, USA)

P4864

Protein A

Santa Cruz (CA, USA)

sc-2001

Protein G

Santa Cruz (CA, USA)

sc-2002

Trizol reagent

Invitrogen (CA, USA)

15596-018

Cyclohexmide

Sigma (MI, USA)

C4859

PfuTurbo DNA Polymerase

Stratagene (CA, USA)

600255

RNase OUT

Invitrogen (CA, USA)
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2.3 Construction of expression plasmid
Proper primers were designed and used to amplify target genes using PCR, which were
followed by enzyme digestion. COP1-C136S/C139S and COP1-S387A mutants were
generated using PCR-directed mutagenesis and verified by DNA sequencing. The pET15b
plasmids (Flag and His tag) expressing Flag-COP1 (1-226 aa), COP1 (216-420 aa), and
COP1 (392-731 aa) were generated using PCR. The ligation reactions were transformed into
DH5α competent cells and colonies were verified by DNA sequences. More information of
plasmids is listed in Table 2-3. Table 2-4 shows that the PCR conditions are used for the
generation of COP1 RING and S387A mutant.

2.4 Immunoprecipitation and immunoblotting
Cells were lysated in lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5%
NP-40, 0.5% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium fluoride, 5
mM sodium orthovanadate, 1 µg each of aprotinin, leupeptin, and pepstatin per ml)
(Laronga et al., 2000). Lysates were processed either by immunoprecipitation assay or by
immunoblotting assay. Samples used for detection of COP1, 14-3-3σ, and p53 were
resolved by 10% SDS-PAGE gels. Samples used for ubiquitination assay were resolved
using 6% gel. Proteins were transferred (Bio-Rad) to polyvinylidene difluoride membranes
(Millipore). The membranes were blocked with 5% nonfat milk for 1 h at room temperature
prior to incubation with indicated primary antibodies. Subsequently membranes were
washed three times with TBST or PBST buffer and incubated for 1 h at room temperature
with

peroxidase-conjugated

secondary

antibodies.

Following

three-time

washes,

chemiluminescent images of immunodetected bands on the membranes were recorded on X22

ray films using the enhanced chemiluminescence (ECL) system according to the
manufacturer's instructions. For immunoprecipitation, cell lysates were pre-cleaned by either
protein A or protein G beads at 4 °C for 30 minutes and immunoprecipitated by indicated
antibodies overnight. On the 2nd day, either protein A or protein G was incubated with the IP
complex for 4 hours. This was then followed by Western blot analysis.

Table 2-3. List of plasmids
Plasmid

Primer Sequence

Vector

Flag-COP1

Provided by Dr. Elisabetta Bianchi

pCMV5

RFP-COP1

COP1-Bgl II was ligated in pDsRed1-C1-Bgl II and CIP)

pDsRed1-C1

GFP-COP1

COP1-Bgl II- 3' filled was ligated in pEGFPC-3-Sma I cut and CIP)

pEGFPC-3

Flag-COP1(1-334 aa)

Provided by Dr. Elisabetta Bianchi

pCMV5

Flag-COP1(401-731 aa) Provided by Dr. Elisabetta Bianchi

pCMV5

Myc-COP1

pCDNA6

COP1-Bgl II was ligated in pDsRed1-C1-EcoRI and CIP)

Bacterial expressed-Flag COP1
1-226

216-420

392-731

5'-CTGCCGCTCGAGTCTGGTAGCCGCCAGGCC

pET15b

5'-CCAGCCCTCGAGTCACAACCAATCTTGAAATATCTGCC

pET15b

5'-CTGCCGCTCGAGGGCCACAGGTGGCAGATATTT

pET15b

5'-CCAGCCCTCGAGTCAACCATTATAGAGATCACTAGC

pET15b

5'-CTGCCGCTCGAGTTTCAGGAATGCTTGTCCAAG

pET15b

5'-CCAGCCCTCGAGTCATACCAATTCTAGCACCTTAA

pET15b

COP1 (RING mutant)

5'-AGCAACGACTTCGTATCCCCCATCTCCTTTGATATGATTGAA pCMV5

shCOP1

5'-CTGACCAAGATAACCTTGATTCAAGAGATCAAGGTTATCTTG pSilencer 1.0-U6
5'-GTCAGTTTTTT

pSilencer 1.0-U6

5'-AATTAAAAAACTGACCAAGATAACCTTGATCTCTTGAATCAA pSilencer 1.0-U6

Flag-COP1 (S387A)

5'-GGTTATCTTGGTCAGGGCC

pSilencer 1.0-U6

5'-GACAGTCGAACTGCAGCCCAGTTGGATGAATTT

pCMV5

5'-AAATTCATCCAACTGGGCTGCAGTTCGACTGTC

pCMV5
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Table 2-4. PCR conditions for mutagenesis

Steps

Temperature Duration

Cycles

Initiation

94°C

5 minutes

1

Denaturation

94°C

60 seconds

Annealing

55°C

60 seconds

Extension

68°C

60 seconds

68°C

30

1

2.5 In vitro binding Assay
For full-length COP1 binding assay, 35S labeled COP1 was produced by TNT quick coupled
Transcription/Translation system in vitro (Promega). TNT products of COP1 were incubated
with GST or GST-14-3-3σ.

To determine which domains of Flag-COP1 bind to 14-3-3σ in vitro, Flag-COP1 fragments
(a.a. 1-226, 216-420, 392-731) were inserted into pET15b vector and transformed into BL21
(DE3). E.coli cells were lysed in the NETN buffer (0.5% NP-40, 20mM Tris, pH 8.0,
100mM NaCl, 1mM EDTA). Lysates were incubated with M2-conjugated agarose beads for
overnight. The immobilized Flag-COP1 was eluted from Flag peptide and then eluents were
incubated with GST-14-3-3σ for the binding. The binding proteins were resolved by SDSPAGE and immunoblottings were detected with anti-M2.

2.6 In vivo ubiquitination Assay
HCT116 14-3-3σ−/− and 14-3-3σ+/+ cells were used to detect endogenous COP1
ubiquitination. 293T cells were cotransfected with indicated plasmids to detect exogenous
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COP1 and p53 ubiquitination. Twenty-four hours later, cells were treated with 5 µg/ml
MG132 for 6 h. Cells were harvested and lysed with regular lysis buffer, containing 5 mM
NEM. The ubiquitinated p53 was immunoprecipitated with anti-p53 and immunoblotted
with anti-ubiquitin or anti-HA. The ubiquitinated COP1 were immunoprecipitated by antiMyc, or anti-COP1, and immunoblotted by anti-HA or anti-ubiquitin. The protein
complexes were then resolved by 6% SDS-polyacrylamide gel to observe the
polyubiquitinated p53 or COP1.

2.7 In vitro ubiquitination Assay
COP1 and COP1 RING mutant (C136S, C139S) cDNAs were transcribed and translated in
vitro using TNT kit (Promega). COP1 and COP1 RING mutant were incubated with either
GST- or GST-14-3-3σ and the complex were incubated with different combination of
ubiquitin (200 pmol), E1 (2 pmol), E2-UbcH5a/5b (10 pmol), and ATP (2 mM) in a total
volume of 50 µl for 1 h at 37oC. Reaction products were immunoprecipitated with M2
beads, immunoblotted with anti-ubiquitin, and resolved by 6% SDS-polyacrylamide gel.

2.8 Quantitative-PCR
Primers for real-time quantitative PCR of COP1 (5’- CTGCAACGGGCTCATCAACT; 5’GGCCACATTTTGTCATGTATGCT). p53 target genes, including CDKN1A (5’CCTGTCACTGTCTTGTACCCT;

5’-GCGTTTGGAGTGGTAGAAATCT),

SFN

(5’-

CTCTCCTGCGAAGAGCGAAAC; 5’- CCTCGTTGCTTTTCTGCTCAA), BAX (5’CCCCGAGAGGTCTTTTTCCG;

5’-

GGCGTCCCAAAGTAGGAGA),

PUMA

(5’-

GACCTCAACGCACAGTACGAG; 5’-AGGAGTCCCATGATGAGATTGT) and p53
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primer (5’ - CCGCAGTCAGATCCTAGCG; 5’ - AATCATCCATTGCTTGGGACG) were
as

referred

by

Primer

Bank

(http://pga.mgh.harvard.edu/primerbank/).

GAPDH

amplification was used for normalization. Total RNAs were extracted from cells using
TRIZOL (Invitrogen). 1µg RNA was used for producing cDNA by iScript cDNA Synthesis
Kit. Real-time PCR analysis was performed using iQ SYBR Green Super mix, and iCycler
iQ Real-time PCR detection system. The amplification folds of genes were analyzed and
visualized by Cluster and TreeView software (Eisen, MB), and presented in the form of heat
maps. Table 2-5 shows the real time-PCR program for amplification of p53 target gene.

Table 2-5. List of real time-PCR program for the amplification of p53 target genes.

Steps

Temperature Duration

Cycles

Initiation

94°C

10 minuts

1

Denaturation

94°C

30 seconds

Annealing

58°C

30 seconds

Extension

72°C

30 seconds

72°C

40

1

2.9 Luciferase reporter gene assay
The BDS2-3X-luc reporter containing a p53-responsive element, p53, Flag-COP1 or Flag14-3-3σ expressing vectors were transfected into H1299 cells. Luciferase activity was
assayed using the dual luciferase assay system (TD-20/20 Luminometer) according to the
manufacturer’s instructions.
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2.10 Generation of stable transfectants
For the generation of 14-3-3σ knock-down stable cells, HCT116 cells were infected by
lentiviral shRNA transduction particles (Sigma, MISSION shRNA lentiviral transduction
particles) containing either control luciferase shRNA or two specific 14-3-3σ shRNA (1) (5'CCGGC CGGGT CTTCT ACCTG AAGAT CTCGA GATCT TCAGG TAGAA GACCC
GGTTT TTG) or 14-3-3σ shRNA (2) (5'-CCGGG ACGAC AAGAA GCGCA TCATT
CTCGA GAATG ATGCG CTTCTT GTCGT CTTTT TG). After infection, cells were
selected with 2µg/ml puromycin for two weeks according to protocols by the manufacturer.

For the generation of RFP-COP1 overexpression stable transfectants, U2OS cells were
transfected with RFP vector or RFP-COP1 plasmids using electroporation (Amaxa). After 2
days, cells were selected in medium containing 500 µg/ml G418 for 4 weeks.

For the generation of Myc-COP1 overexpression stable transfectants, HCT116 cells were
transfected with either pCDNA6 or pCDNA6-Myc-COP1 plasmids by electroporation
(Amaxa). After 2 days, cells were selected in medium containing 8 µg/ml blasticidin for 2
weeks.

2.11 Live-cell imaging
RFP-COP1 expressing cells were treated with DNA damage agent, including 1 µg/ml
doxorubicin, IR (10 Gy) or infected with Ad-β-gal (MOI = 100) or Ad-14-3-3σ (MOI
=100). Live-cell images of stably expressing RFP-COP1 cells were observed with Olympus
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FV300 and ZEISS LSM 710 confocal microscopes. Both of them are fully motorized
incubator chambers that maintain cells at 37 °C in 5% CO2.

2.12 Cell fractionation
Cells were lysed in 500 – 1000 µl cold lysis buffer (10 mM MgCl2, 10 mM Tris, pH 7.6,
0.5% NP-40, 1 µM DTT, phosphatase inhibitors and proteasome inhibitors), and keep on ice
less than 30 min. Cells were broken using a glass homogenizer (20 strokes). The dounced
lysates ware centrifuged (4,000 rpm for 5 min at 4°C) to sediment the nuclei portion and
other fragments. The supernatant was then prepared (13,200 rpm for 10 – 20 minutes) and
the supernatant was saved for the cytoplasmic fraction. The nuclear pellet was washed for
three times. Nuclear pellet were resuspended in 150 µl regular lysis buffer and sonicated to
extract nuclear proteins on ice. The nuclear lysates ware centrifuged (13,200 rpm for 30
minutes), and the supernatant was the nuclear fraction.

2.13 Soft agar colony formation
For soft agar colony assays, 3 x 103 cells mixed in 0.35% agarose/complete media were
plated on 0.7% agarose/complete media bottom layer (Invitrogen) in appropriate culture
medium and grown for 4 weeks. Colonies were stained with 0.5 mg/ml piodonitrotetrazolium violet (Sigma) and were counted under a light microscope (Olympus
IX70 and IX71). Each experiment was done at least two times in triplicate wells.

2.14 Foci formation assay
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One, two, or three thousand cells were plated in 6-multiwell plates and then incubated for 7
− 10 days. Cells were stained with 0.005% crystal violet to visualize the colonies growing in
each well. The 6-multiwell plates containing colonies were scanned by the scanner and the
number of colonies were determined by counting in images.

2.15 MTT Assay
Vector control or COP1 expressing cells or COP1 expressing cells were infected with Ad-βgal (MOI = 10) or Ad-HA-14-3-3σ (MOI =100). Cells were plated at 3x103 cells/well in 96multiwell plates in triplicate and grown in the continued presence of selective antibiotics.
Cells viability was determined every day from day 1 to 7 by incubation with 5 mg/ml MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) for 3 h. Following MTT
incubation, cells were lysed in 200 µl of 100% DMSO (Fisher). The samples were then
analyzed using a microplate reader to measure the optical density at 570 nm.

2.16 Cell cycle analysis
2x106 cells were collected by centrifugation, washed with PBS (pH 7.4), fixed with ethanol
and incubated with Propidium Iodide (50 µg/ml). Fluorescence signal resulting from PI was
measured at 630 nm. 10,000 events per sample were acquired. Samples were analyzed by
BD FACSCANTO II flow cytometer (BD Biosciences).

2.17 Nude mice experiment
Four to 6-week-old nu/nu mice (Charles River Laboratories) were maintained in the animal
facility at the University of Texas M. D. Anderson Cancer Center. Mice were divided into
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four experimental groups, five for each. Groups included vector control stable cell lines,
COP1 expressing cells left uninfected, COP1 expressing cells infected with Ad-β-gal (MOI
= 100) or Ad-14-3-3σ (MOI =100) for forth to eight hours. Cells were harvested and
injected into the flanks of each mouse. Tumor volumes were measured and recorded three
times a week from day 10 after cell inoculation. At the end of experiment, the mice were
sacrificed, and the tumors were removed and weighed.

2.18 Immunohistochemistry
A pancreatic tissue microarray consisting of 121 cases of primary pancreatic carcinoma
specimens from patients who underwent initial pancreaticoduodenectomy was used for
immunohistochemistry of 14-3-3σ and COP1. These microarray patience resources were
from The University of Texas M. D. Anderson Cancer Center (MDACC) between 1990 and
2004. None of these patients received pre-operative chemotherapy or radiation therapy
before surgery. The use of archival paraffin-embedded tissue blocks was in accordance with
a protocol approved by the Institutional Review Board of MDACC. 5-µm unstained sections
in the tissue microarray blocks were performed for immunohistochemistry of 14-3-3σ and
COP1. To retrieve the antigenicity, deparaffinized sections were treated at 100 ºC in a
steamer containing 10 mM citrate buffer (pH, 6.0) for 60 min. The sections were then
immersed in methanol containing 0.3% hydrogen peroxidase for 20 min to inhibit
endogenous peroxidase activity and then incubated in 2.5% blocking serum to block
nonspecific binding. Sections were incubated with primary antibodies against 14-3-3σ and
COP1 at a 1:100 dilution (90 min at 37°C). Standard avidin-biotin immunohistochemical
analysis of the sections was performed according to the instructions by the manufacturer
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(Vector Laboratories, Burlingame, CA). Diaminobenzidine was used as a chromogen, and
hematoxylin was used for counterstaining. The staining results were analyzed by a boardcertified pathologist (H.Wang). The scores, 0 (no nuclear staining); 1(<10% nuclear
staining); 2 (10-50% nuclear staining) and 3 (>50% nuclear staining), were used for
analyzing for standard of COP1 levels.
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CHAPTER 3. RESULTS

3.1 14-3-3σ is required for doxorubicin-mediated COP1 downregulation
It is known that 14-3-3σ is a p53 target (Hermeking et al., 1997). DNA damage leads to
p53 activation and stabilization, which in turn induces 14-3-3σ to execute G2/M arrest
(Hermeking et al., 1997). COP1, a p53 E3 ligase, ubiquitinates and degrades p53 (Dornan et
al., 2004b). Given that COP1 has a shorter half-life following DNA damage, we address
whether 14-3-3σ is involved in DNA damage-mediated COP1 downregulation. To test our
hypothesis, we treated A549 cells (Human lung adenocarcinoma epithelial cell line) with
doxorubicin for the indicated time points, followed by immunoblotting assays. Indeed, as
doxorubicin-induced DNA damage increased the levels of 14-3-3σ, COP1 expression was
downregulated (Figure 3-1). This suggests that 14-3-3σ and COP1 may have a negative
relationship following DNA damage. Furthermore, we found that DNA damage-mediated
COP1 downregulation was rescued when A549 cells were treated with MG132, a
proteasome inhibitor (Figure 3-2). This result indicates that doxorubicin-mediated COP1
downregulation is through 26S proteasome pathway. Figure 3-1 shows that 14-3-3σ is
involved in COP1 downregulation following genotoxic challenges. We further clarify
whether disruption of 14-3-3σ compromises doxorubicin-mediated COP1 downregulation.
Interestingly, downregulation of COP1 upon doxorubicin-induced DNA damage was
observed in HCT116 14-3-3σ+/+ cells, but was absent in HCT116 14-3-3σ−/− cells (Figure 33). This result implies that 14-3-3σ is required for DNA damage-mediated COP1
downregulation.
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Figure 3-1. COP1 expression is downregulated in response to DNA damage. A549 cells
were treated with 1 µg/ml of doxorubicin (DOX) for the indicated times. Lysates were
analyzed by immunoblotting for the expression of 14-3-3σ, COP1 and p53.
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Figure 3-2. DNA damage-mediated COP1 downregulation is mitigated by the
treatment with MG132. A549 cells were treated with 1 µg/ml of doxorubicin (DOX) for
the indicated times and treated with or without proteasome inhibitor MG132 for 3 hours
before harvesting. Lysates were collected at the indicated times and analyzed by
immunoblotting with indicated antibodies. The protein levels of COP1 in response to DNA
damage at the different time points were determined by measuring the integrated optical
intensity of the bands in the immunoblots (bottom).
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Figure 3-3. DNA damage-mediated COP1 downregulation is recovered in 14-3-3σ null
cells. HCT116 14-3-3σ+/+ and HCT116 14-3-3σ−/− cells were treated with doxorubicin
(DOX) for the indicated times. Cell lysates were immunoblotted with anti-14-3-3σ, antiCOP1, and anti-tubulin (top). The protein levels of COP1 in response to DNA damage at the
different time points were determined by measuring the integrated optical intensity of the
bands in the immunoblots (bottom). The level of COP1 at time 0 is set at 100%.
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3.2 14-3-3σ-mediated COP1 downregulation is 26S proteasome-dependent
Given that 14-3-3σ is required for DNA damage-mediated COP1 downregulation and 143-3σ is a positive regulator of p53 (Yang et al., 2003), we further examine whether 14-3-3σ
negatively regulates the stability of COP1. We generated lentiviral shRNA-mediated
knockdown of 14-3-3σ in HCT116 cells. We found that endogenous COP1 steady-state
levels were accumulated in 14-3-3σ knockdown cells (Figure 3-4 A). To confirm the role of
14-3-3σ in the stability of COP1, we used 293T cells, a 14-3-3σ null cell line, and
transfected COP1 and increasing amount of 14-3-3σ in 293T cells. The results showed that
an increasing amount of 14-3-3σ led to COP1 downregulation (Figure 3-4 B). We found that
14-3-3σ does not reduce mRNA levels of COP1 (data not shown). Given that 14-3-3σ
decreases the steady-state levels of COP1 (Figure 3-4), we further measure whether 14-3-3σ
shortens the half-life of COP1. HCT116 14-3-3σ+/+ and HCT116 14-3-3σ−/− cells were
treated with cycloheximide (CHX), a protein synthesis inhibitor. We found that the half-life
of endogenous COP1 was reduced in the presence of 14-3-3σ compared to COP1 levels in
the absence of 14-3-3σ cells (Figure 3-5). This suggests that 14-3-3σ plays a role in COP1
degradation. It is interesting to further investigate whether 14-3-3σ-mediated COP1
degradation is dependent on 26S proteasome. Consistent with doxorubicin-mediated COP1
downregulation (Figure 3-2), we found that 14-3-3σ-mediated COP1 degradation was
recovered by MG132 treatment (Figure 3-6).
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(A)

(B)

Figure 3-4. 14-3-3σ downregulates steady-state levels of COP1. (A) 14-3-3σ decreases
COP1 steady state. 14-3-3σ was stably knocked down with shRNA 1 (1) and shRNA 2 (2)
in HCT116 cells. Luciferase shRNA was used as control (C). Lysates were immunoblotted
with anti-COP1, and 14-3-3σ. (B) Ectopic 14-3-3σ expression leads to COP1
downregulation. The indicated plasmids were transfected in 293T cells. Equal amounts of
cell

lysates

were

immunoblotted
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with

the

indicated
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Figure 3-5. The half-life of COP1 is prolonged in 14-3-3σ null cells. HCT116 14-3-3σ+/+
and HCT116 14-3-3σ−/− cells were treated with cycloheximide (CHX) for the indicated
times. Cell lysates were immunoblotted with anti-14-3-3σ, anti-COP1, and anti-tubulin
(top). The protein levels of COP1 over time are shown (bottom).
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Figure 3-6. 14-3-3σ downregulates COP1 through 26S proteasome pathway. 293T cells
were transfected with the indicated plasmids. Cells were treated with or without proteasome
inhibitor MG132 for 6 hours before lysates were collected. Lysates were immunoblotted
with anti-Flag or anti-tubulin.
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3.3 Identification of COP1 binding region on 14-3-3σ and 14-3-3σ binding region on
COP1
In order to explore the molecular mechanism of 14-3-3σ-mediated downregulation of COP1
following DNA damage, we first address whether 14-3-3σ interacts with COP1. A549 cells
were treated with doxorubicin overnight in order to induce 14-3-3σ levels. Using reciprocal
co-immunoprecipitation, we found that COP1 bound to 14-3-3σ under physiological
conditions (Figure 3-7). We further detected a direct binding between 14-3-3σ and COP1.
COP1 was produced in an in vitro transcription coupled with translation reaction, and then
we performed GST pull-down assays. Interestingly, COP1 directly bound to 14-3-3σ (Figure
3-8). To further identify the binding domains on each protein, we first define the region of
COP1 that is required for binding to 14-3-3σ. We generated different bacterial expressed
COP1 fragments (1 aa-226 aa, 216 aa-420 aa, and 392 aa-731 aa containing RING, coiledcoil, and WD40 repeat domains, respectively). Different COP1 fragments were incubated
with GST or GST-14-3-3σ. We found that 14-3-3σ directly bound to RING finger and
coiled-coil region of COP1 (Figure 3-9). On the other hand, to define the region of 14-3-3σ,
which is required for binding to COP1, 293T cells were transfected with Myc-COP1 and
different 14-3-3σ fragments (full-length, 1 aa-161 aa, and 153 aa-248 aa). We found that
COP1 bound to N-terminus of 14-3-3σ. This indicates that the N-terminus of 14-3-3σ binds
to

RING-finger

and

coiled-coil

domain
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of

COP1

(Figure

3-10).

Figure 3-7. Endogenous 14-3-3σ binds to endogenous COP1. Endogenous 14-3-3σ
interacts with endogenous COP1. A549 cells were treated with 1 µg/mL doxorubicin
overnight. Before harvesting, cells were treated with a proteasome inhibitor, MG132 for six
hours. Equal amounts of cell lysates were immunoprecipitated with either rabbit IgG (as
control) or anti-COP1, and immunoblotted with anti-14-3-3σ (top panel). Lysates were also
immunoprecipitated with either mouse IgG (as control) or anti-14-3-3σ and immunoblotted
with anti-COP1 (bottom panel). WCL: whole cell lysate.
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Figure 3-8. 14-3-3σ directly binds to COP1. 14-3-3σ specifically interacts with COP1 in
vitro. COP1 cDNAs were transcribed and translated in vitro. 35S-labeled COP1 proteins were
incubated with either GST- or GST-14-3-3σ and analyzed by SDS-PAGE and
autoradiography. The bottom panel shows the input of GST and GST-14-3-3σ analyzed by
Coomassie Blue staining. PD: pull down.
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Figure 3-9. Map of the 14-3-3σ binding region within COP1. Bacterially expressed FlagCOP1 domains were eluted with Flag-peptide. GST-14-3-3σ was incubated with eluents of
bacterially expressed Flag-COP1 domains, and then the mixture was subjected to GST pulldown (PD) followed by immunoblotting using anti-Flag. Specific interaction of COP1
domains with 14-3-3σ is indicated by arrows. The asterisks indicate non-specific bands.
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Figure 3-10. Identification of 14-3-3σ domains interacts with COP1. 293T cells were
cotransfected with Myc-COP1 and wild-type (aa 1-248), N-terminus (aa 1-161), or Cterminus (aa 153-248) of Flag-14-3-3σ. Before harvesting, cells were treated with
proteasome inhibitors. Lysates were immunoprecipitated with anti-Myc and immunoblotted
with anti-Flag. Specific interactions of 14-3-3σ domains with COP1 are indicated. The
asterisk marks the IgG light chain.
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3.4 14-3-3σ promotes COP1 ubiquitination
Given that 14-3-3σ affects the instability of COP1 (Figure 3-5), 14-3-3σ -mediated
COP1 downregulation is 26S proteasome-dependent (Figure 3-6), we address that 14-3-3σ
may participate in COP1 ubiquitinated proteolysis. 293T cells were transfected with MycCOP1, HA-ubi, and increasing amount of Flag-14-3-3σ. We found that increasing 14-3-3σ
expression facilitated COP1 polyubiquitination (Figure 3-11). To determine whether 14-33σ-promoted COP1 ubiquitination occurs under physiological conditions, we performed
ubiquitination assay in HCT116 14-3-3σ+/+ and HCT116 14-3-3σ−/− cells. More COP1
ubiquitination was detected in HCT116 14-3-3σ+/+ cells than in HCT116 14-3-3σ−/− cells
(Figure 3-12). Consistently, less COP1 ubiquitination was detected in 14-3-3σ knockdown
HCT116 cells compared to those in HCT116 14-3-3σ+/+ cells (Figure 3-13). We were further
interested in exploring COP1 self-ubiquitination using in vitro ubiquitination assay.
Bacterial expressed COP1 was incubated with GST or GST-14-3-3σ. Interestingly COP1
polyubiquitination was enhanced by GST-14-3-3σ. Additionally COP1 lost its selfubiquitination activity when cysteines at positions 136 and 139 within the RING finger were
mutated (Figure 3-14). It indicates that 14-3-3σ facilitates COP1 self-ubiquitination and
RING domain is necessary for 14-3-3σ-mediated COP1 self-ubiquitination. It will be
interesting to address whether 14-3-3σ has a negative impact on the turnover rate of COP1
RING mutant (C136S/C139S) determine whether 14-3-3σ facilitates either Lys-48 or Lys63 ubiquitin chain of COP1.
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Figure 3-11. 14-3-3σ enhances polyubiquitination of COP1. 293T cells were
cotransfected with the indicated plasmids and increasing amounts of Flag-14-3-3σ. The cells
were treated with MG132 for 6 hr before harvesting, and the ubiquitinated COP1 was
immunoprecipitated with anti-Myc and immunoblotted with anti-HA. Equal amounts of
whole cell lysate (WCL) were immunoblotted with anti-Myc, anti-Flag, or anti-tubulin.

46

Figure 3-12. COP1 ubiquitination is reduced in 14-3-3σ-null cells. HCT116 14-3-3σ−/−
and HCT116 14-3-3σ+/+ cells were treated with MG132 for 6 hr before harvesting.
Polyubiquitinated COP1 was detected by immunoprecipitation with anti-COP1 and
immunoblotting with anti-ubiquitin in indicated cells.
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Figure 3-13. COP1 ubiquitination is reduced in 14-3-3σ knockdown cells. 14-3-3σ
knockdown cells were created by stably infecting HCT116 cells with two specific 14-3-3σ
shRNA (1 & 2). Luciferase shRNA was used as a control (C). Lysates were
immunoprecipitated with anti-COP1 and immunoblotted with anti-ubiquitin.
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Figure 3-14. 14-3-3σ promotes COP1 self-ubiquitination. Flag-COP1 and Flag-COP1
RING

(C136S,

C139S)

mutant

proteins

were

made

using

an

in

vitro

Transcription/Translation system (TNT) and then incubated with the indicated purified GST
proteins. Polyubiquitinated COP1 was examined by immunoprecipitating with anti-Flag,
followed by immunoblotting with anti-ubiquitin (top panel). The bottom panel shows the
input of GST proteins (Coomassie Blue staining).
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3.5 14-3-3σ affects COP1 subcellular localization
Given that COP1 contains NES and NLS (Yi et al., 2002), COP1 is nuclear-cytoplasmic
repartitioning. Arabidopsis COP1 localization is shuttling between the nucleus and
cytoplasm and is regulated by light (Osterlund et al., 2000). In mammal, it has been
demonstrated that endogenous COP1 localization is regulated by DNA damage using the
fractionation assay (Dornan et al., 2006). To confirm this observation, we observed COP1
localization in NIH3T3 cells expressing RFP-COP1 in live cells. Time-lapse confocal
microscopy showed that COP1 formed punctate foci (Figure 3-15 A) and COP1 shuttled
between the nucleus and cytoplasm in unstressed cells (Figure 3-15 B, top panel); however,
COP1 shuttling to the nucleus was blocked in ionizing radiation-treated cells (Figure 3-15 B,
bottom panel). It indicates that IR blocks COP1 shuttling from the cytoplasm to the nucleus.
In Figure 3-16, cell fractionation assay showed that cytoplasmic portions of COP1 were
increased in cells treated with doxorubicin or IR compared to those in unstressed cells. It
suggests DNA damage-induced COP1 nuclear exclusion. Given that 14-3-3σ is induced by
DNA damage and have an effect on regulating the subcellular localization of its targets
(Rittinger et al., 1999), U2OS cells stably expressing RFP-COP1 were infected with Ad-βgal or Ad-14-3-3σ. COP1 was shuttled between the cytoplasm and nucleus when cells were
infected with Ad-β-gal as observed by confocal microscopy. However, COP1 shuttling was
blocked when cells were infected with Ad-14-3-3σ. Cell fractionation also confirmed that
cytoplasmic COP1 levels increased in 14-3-3σ-infected cells compared to Ad-β-gal-infected
cells (Figure 3-17). Together, COP1 localization is accumulated to the cytoplasm in
response to DNA damage and in 14-3-3σ-infected cells.
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Next we address the specific role of 14-3-3σ in IR-induced COP1 translocation to the
cytoplasm. We further detected cytoplasmic and nuclear COP1 portion by irradiating
HCT116 14-3-3σ+/+ and HCT116 14-3-3σ−/− cells. We found that IR-induced COP1
translocation from the nucleus to the cytoplasm was impaired in HCT116 14-3-3σ−/− cells
compared to HCT116 14-3-3σ+/+ cells (Figure 3-18A). Consistently, COP1 translocation
from the nucleus to the cytoplasm was compromised in 14-3-3σ knockdown cells (Figure 318B). Taken together, 14-3-3σ plays a critical role in the nuclear export of COP1.

It is know that 14-3-3σ’s NES is required for its target’s translocation to the cytoplasm
(Rittinger et al., 1999). To examine whether 14-3-3σ’s NES is required for mediating COP1
nuclear export, RFP-14-3-3σ NES (I205A, L208A) mutant or 14-3-3σ (WT) were
constructed and cotransfected with GFP-COP1 in U2OS cells. Using immunofluorescnece
microscopy, we found that localization of COP1 was more in the nucleus when cells were
transfected with RFP-14-3-3σ NES (I205A, L208A) mutant (Figure 3-19). It suggests that
COP1 nuclear export is required for 14-3-3σ NES signal.
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Figure 3-15. COP1 nuclear accumulation is blocked in IR-induced cells using confocal
microscopy. (A) COP1 is shuttling between the cytoplasm and nucleus. Live-cell imaging is
captured in NIH3T3 cells expressing RFP-COP1. Typical subcellular localization of RFPCOP1 (red, indicated by arrow) is shown. Hoechst 33342 (0.04 μg/mL) was added for DNA
staining (blue). Merged image containing phase-contrast image is also indicated. Scale bar,
10 μm. (B) Dynamic shuttling of RFP-COP1 in NIH3T3 cells was abolished when cells
were treated with ionizing radiation (IR, 10Gy). Images were captured at 20-min intervals.
The minutes indicate the elapsed time since the first picture was taken (30 min after
treatment).
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Figure 3-16. The portion of cytoplasmic COP1 is increased in response to doxorubicin
and IR using cell fractionation. In U2OS cells, stably expressing RFP-COP1 was treated
with 1 µg/mL doxorubicin (DOX) or 10 Gy ionizing radiation (IR). Subcellular localization
of RFP-COP1 was shown by immunoblotting. Lamin B1 was used as the marker of nuclear
(N) fraction, while α-tubulin was used as the marker for cytoplasmic (C) fraction.
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Figure 3-17. COP1 shuttling is blocked by ectopic 14-3-3σ expression. 14-3-3σ inhibits
COP1 nuclear shuttling. RFP-COP1-expressing cells were infected with Ad-β-gal or Ad-143-3σ. Live-cell images were collected using a confocal microscope at the indicated time
points (top). Arrows indicate the representative COP1 translocation from the cytoplasm to
the nucleus in the Ad-β-gal treatment group and the lack of nuclear migration in the Ad-143-3σ group. Bar graph shows the percentage of COP1 staining increase in the nucleus in
each group (bottom, left panel). Scale bar= 10 μm. Error bars represent 95% confidence
intervals. Cell fractionation of RFP-COP1 in each group is shown by immunoblotting. (N),
nuclear fraction. (C), cytoplasmic fraction (bottom, right panel).
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Figure 3-18. COP1 shuttling is blocked to the cytoplasm in 14-3-3σ-null and
knockdown cells. (A) Cytoplasmic COP1 localization is compromised after DNA damage
in 14-3-3σ-null cells. HCT116 14-3-3σ+/+ and HCT116 14-3-3σ-/-cells were treated with 10
Gy IR. Cytoplasmic and nuclear extracts were prepared 2 hr after irradiation. N, nuclear
fraction. C, cytoplasmic fraction. (B) Cytoplasmic COP1 localization is reduced in 14-3-3σ
knockdown cells after IR. HCT116 cells were stably transfected with two specific 14-3-3σ
shRNA (1 & 2). Luciferase shRNA was used as a control (C). Cytoplasmic and nuclear
extracts were prepared 2 hours after cells were treated with 10 Gy IR.
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Figure 3-19. 14-3-3σ nuclear export signal is required for mediating cytoplasmic
accumulation of COP1. Flag-14-3-3σ wild type (WT), RFP-14-3-3σ NES (I205A, L208A)
or GFP-COP1 mutant plasmids were cotransfected into U2OS cells. Live-cell images of
GFP-COP1 localization were observed using a fluorescence microscope (top).
Quantification of the nuclear localization of COP1 are shown as a bar graph (bottom). Error
bars represent 95% confidence intervals. Scale bar, 10 µm.
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3.6 14-3-3σ binding to COP1 is phosphorylation-dependent
It is known that 14-3-3 preferentially binds to target proteins at the sequences matching
the consensus motif RSXpS/pTXP and RXXXpS/pTXP, where pS/pT represents
phosphoserine and phosphothreonine (Hermeking et al., 1997). We analyzed the COP1
sequence and found that COP1 has a putative 14-3-3σ binding motif, located at Ser 387.
This motif (RTAS387QL) is evolutionarily conserved in mammals (Figure 3-20). We
hypothesized that interaction between 14-3-3σ and COP1 is phosphorylation-dependent
since other known targets of 14-3-3σ are phosphorylated prior to 14-3-3σ binding. To test
this hypothesis, lysates from cells stably expressing Flag-COP1 were treated with or without
phosphatase inhibitors (sodium fluoride and sodium orthovanadate). We found that the
levels of binding between 14-3-3σ and COP1 were accumulated when cells were treated
with phosphatase inhibitors (Figure 3-21). We will further confirm the binding between
COP1 and 14-3-3σ in CIP-treated cells. It indicates that binding is dependent on
phosphorylation

of

COP1.

To

further

confirm

whether

ATM-mediated

COP1

phosphorylation is required for 14-3-3σ binding, we detected COP1 and 14-3-3σ in ataxiatelangiectasia mutated protein (ATM-/-) fibroblasts without and with full-length cDNA
(AT22IJE-T and AT22IJE-TpEBS7-YZ5). The levels of binding between COP1 and 14-33σ increased when cells were irradiated in the presence of ATM but binding was
compromised in the absence of ATM (Figure 3-22). Since COP1-S387 is phosphorylated by
ATM (Dornan et al., 2006) and binding between COP1 and 14-3-3σ is phosphorylationdependent (Figure 3-21), we examine whether phosphorylation of COP1 at Ser 387 is
required for binding between 14-3-3σ and COP1. We mutated serine to alanine at COP1 at
S387 and coimmunoprecipitation showed that COP1 (S387A) mutant lost the binding for
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14-3-3σ (Figure 3-23). It indicates that COP1-S387 phosphorylation is required for the
binding between14-3-3σ and COP1.
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Figure 3-20. COP1 contains 14-3-3σ consensus binding motif. (A) Sequences of COP1
and other known 14-3-3 substrates are shown for comparison. (B) Sequence alignment of
COP1 containing 14-3-3 binding motifs among different species is shown. The consensus
14-3-3 binding motif is highlighted.
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Figure 3-21. Binding between 14-3-3σ and COP1 is phosphorylation-dependent.
Lysates of U2OS cells stably expressing Flag-COP1 were treated with or without sodium
fluoride and sodium orthovanadate. Before harvesting, cells were treated with proteasome
inhibitors. Lysates were incubated with purified GST-14-3-3σ or GST and immunoblotted
with anti-Flag. PD: pull down.
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Figure 3-22. ATM facilitates the binding between 14-3-3σ and COP1. AT22IJET/pEBS7 (ATM-/-) and AT22IJE-T/YZ5 (ATM+/+) cells were treated with MG132 for 6 hrs
before harvesting and were prepared at 0 (-) and 1 hr (+) after cells were treated with 10 Gy
IR. Lysates were immunoprecipitated with anti-14-3-3σ and immunoblotted with antiCOP1.

64

Figure 3-23. COP1 (S387A) abolishes binding to 14-3-3σ in vivo. 293T cells were
transfected with Flag-14-3-3σ, Myc-COP1 (WT), and Myc-COP1 (S387A). Lysates were
immunoprecitated with ant-Myc and then immunoblotted with anti-Flag.
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3.7 COP1 S387 phosphorylation is required for 14-3-3σ-mediated COP1 nuclear export
14-3-3, which functions as an adaptor protein, can bind and change the subcellular
localization of its targets (Rittinger et al., 1999). Given that ectopic 14-3-3σ promotes
nuclear export of COP1 (Figure 3-17), COP1 is accumulated in the nucleus in 14-3-3σ
knockout cells, and COP1-S387 phosphorylation is required for 14-3-3σ binding. We further
investigate whether 14-3-3σ induces nuclear export of COP1 is dependent on S387
phosphorylation. 293T cells were cotransfected with Flag-COP1 (wt) and Flag-COP1
(S387A). We detected nuclear and cytoplasmic COP1 fraction using a fractionation assay
and found that cytoplasmic COP1 (wt) fraction was increased when cells were infected with
Ad-14-3-3σ compared to cells infected with control Ad-β-gal. However, the increase of
cytoplasmic COP1 (S387A) portion was inhibited when cells were infected by Ad-14-3-3σ
following DNA damage, indicating that 14-3-3σ-mediated COP1 nuclear export is required
for S387 phosphorylation of COP1 (Figure 3-24). We confirmed this result using confocal
microscopy. Following DNA damage, GFP-COP1 dynamic shuttling was blocked to the
nucleus when cells transfected with 14-3-3σ. However, GFP-COP1 (S387A) dynamic
shuttling was resistant to 14-3-3σ-mediated nuclear-export effect (Figure 3-25). Together,
these results suggest that 14-3-3σ is required for IR-induced COP1 nuclear exclusion and
14-3-3σ –mediated nuclear export of COP1 in dependent on phosphorylated COP1 at Ser
387.
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Figure 3-24. 14-3-3σ-induced COP1 translocation to the cytoplasm is S387
phosphorylation-dependent. 293T cells were transfected with the indicated plasmids.
Cytoplasmic and nuclear extracts were prepared 2 hours after 10 Gy IR.
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Figure 3-25. 14-3-3σ-induced COP1 translocation to the cytoplasm is S387
phosphorylation-dependent. U2OS cells were transfected with the indicated plasmids.
GFP-COP1 localization of live-cell images were captured using a confocal microscope
(top). Cytoplasmic and nuclear extracts were prepared 2 hours after 10 Gy IR. Percentage of
COP1 localization in the nucleus is measured and shown as a bar graph at 2 hr after 10 Gy
IR (bottom).
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3.8 COP1-S387 phosphorylation is important for 14-3-3σ-mediated COP1 degradation
Since 14-3-3σ causes the instability of COP1 (Figure 3-4, 3-5, 3-6) and 14-3-3σ binds to
phosphorylated COP1 at S387 (Figure 3-23), we hypothesize that COP1-S387A expression
may abolish 14-3-3σ-mediated COP1 degradation. 293T cells were transfected with either
COP1 (wt) or COP1 (S387A). The levels of wild-type COP1 steady-state were decreased in
a dose-dependent manner when cells were transfected 14-3-3σ. However, the steady-state
level of COP1 (S387A) was not affected by the expression of 14-3-3σ (Figure 3-26). We
further showed that the turnover rate of COP1 was facilitated by 14-3-3σ expression; while
the turnover rate of COP1 (S387A) was not affected by 14-3-3σ expression (Figure 3-27). In
addition, COP1 ubiquitination was facilitated by 14-3-3σ while COP1 (387A) ubiquitination
was not affected by 14-3-3σ (Figure 3-28). Given that 14-3-3σ is involved in DNA damageinduced COP1 translocation to the cytoplasm and facilitates COP1 ubiquitination, we
investigate whether 14-3-3σ promotes cytoplasmic COP1 ubiquitination in the response to
DNA damage. More cytoplasmic COP1 ubiquitination was detected in HCT116 14-3-3σ+/+
cells treated with 10 Gy IR compared with no IR treatment (lane 1 and lane 2 in Figure 329). At the same time, we found that cytoplasmic COP1 ubiquitination was reduced in
HCTT16 14-3-3σ-/- cells compared to HCT116 14-3-3σ+/+ cells (lane 2 and lane 4 in Figure
3-29). Taken together, ATM-induced COP1 S387 phosphorylation is required for 14-3-3σmediated COP1 nuclear export and ubiquitination in the cytoplasm.
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Figure 3-26. 14-3-3σ downregulates the steady state of COP1 (WT) but not COP1
(S387A). 293T cells were cotransfected with the indicated Flag-COP1 (WT), Flag-COP1
(S387A), and Flag-14-3-3σ. Cell lysates were immunoblotted with anti-Flag,and antitubulin
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Figure 3-27. 14-3-3σ facilitates turnover rate of COP1 (WT) but not COP1
(S387A). 293T cells were contresfected as Figure 3-26. Before harvesting, cells were treated
with cycloheximide (CHX) for the indicated times. Cell lysates were immunoblotted with
anti-Flag,and anti-tubulin.
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Figure 3-28. 14-3-3σ promotes COP1 (WT) but not COP1 (S387A) polyubiquitination. 293T cells were contresfected with indicated Myc-COP1 (WT), Myc-COP1
(S387A), and Flag-14-3-3σ. The cells were treated with MG132 for 6 h before harvest, and
the ubiquitinated COP1 was immunoprecipitated with anti-Myc and immunoblotted with
anti-HA. Equal amounts of lysates were immunoblotted with anti-Myc, anti-Flag, or antitubulin.
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Figure 3-29. 14-3-3σ promotes cytoplasmic COP1 polyubiquitination in response to
DNA damage. HCT116 14-3-3σ+/+ (lanes 1 and 2) and HCT116 14-3-3σ-/- (lanes 3 and 4)
were treated with MG132 for 6 hrs before harvesting. Cytoplasmic extracts were prepared at
0 and 2 hr after cells were treated with 10 Gy IR. Cytoplasmic polyubiquitinated COP1 was
detected by immunoprecipitation with anti-COP1 and immunoblotting with anti-ubiquitin in
indicated cells.
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3.9 14-3-3σ blocks COP1-mediated p53 degradation and transcriptional repression
Previous evidence has shown that COP1 is a p53 E3 ligase (Dornan et al., 2004a) and
previous data have shown that 14-3-3σ binds to COP1 and promotes COP1 ubiquitination
(Figure 3-7 and 3-11). We further studied whether 14-3-3σ blocks COP1-mediated p53
degradation. 293T cells were cotransfected with Flag-COP1, GFP-p53, and increasing
amount of 14-3-3σ. As we expected, the steady state levels of p53 was lowered by COP1. At
the time, increasing amount of 14-3-3σ degraded COP1 and blocked COP1-mediated p53
degradation (Figure 3-30). 14-3-3σ negative impacts on COP1-mediated p53 degradation
will be confirmed in endogenous p53 levels. We further transfected p53, Flga-COP1, and
Flag-14-3-3σ in H1299 (p53 null) to detect p53 ubiquitination. We found that increasing
amount of 14-3-3σ blocked COP1-mediated p53 ubiquitination (Figure 3-31). To exclude
the contribution of MDM2, a p53 E3 ligase, on p53 ubiquitination, p53-/- MDM2-/- MEF cells
were transfected with the same plasmids. We found that 14-3-3σ still blocked COP1promoted p53 ubiquitination (Figure 3-32). This suggests that 14-3-3σ’s negative impact on
COP1-mediated p53 ubiquitination is independent of negative impacts on MDM2-mediated
p53 ubiquitination.

To study the biological consequence of 14-3-3σ’s negative impact on COP1-mediated
p53 degradation and ubiquitination, we analyze gene expression of p53 target genes in two
p53-positive cell lines (colon carcinoma HCT116 and osteosarcoma U2OS) using real-time
PCR. We found that mRNA levels of p53 target genes, including CDKN1A, SFN, BAX, and
PUMA, were reduced in Myc-COP1 or RFP-COP1 overexpressing cell lines. However,
mRNA levels of p53 targets were accumulated in COP1 overexpression cells infected with
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Ad-14-3-3σ compared with cells infected Ad-β-gal (Figure 3-33). To further confirm p53
transcriptional activity using a luciferase reporter gene assay, H1299 (p53 null) cells were
transfected with a 14-3-3σ reporter containing a p53-binding element in the promoter, p53,
COP1, and/or 14-3-3σ plasmids. We found that 14-3-3σ antagonized COP1-mediated p53
transcriptional repression (Figure 3-34). Taken together, the data suggests that 14-3-3σ
negatively regulates COP1, blocks COP1-mediated p53 degradation, and inhibits COP1mediated p53 transcriptional repression.
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Figure 3-30. 14-3-3σ antagonizes COP1-mediated p53 degradation. 293T cells were
cotransfected with the indicated Flag-COP1, His-p53, and increasing amounts of 14-3-3σ.
Lysates were immunoblotted with anti-His, anti-Flag or tubulin.
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Figure 3-31. 14-3-3σ inhibits COP1-mediated p53 polyubiquitination. H1299 cells were
cotransfected with the indicated HA-ubiquitin, Flag-COP1, p53, and increasing amounts of
Flag-14-3-3σ. Cells were treated with MG132 before harvesting. Lysates were
immunoprecipitated with anti-p53 and immunoblotted with anti-HA.
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Figure 3-32. 14-3-3σ reduces COP1-mediated poly-ubiquitination of p53 regardless of
the deficiency of MDM2. p53−/−MDM2−/− MEF cells were cotransfected with the indicated
Myc-COP1, p53, HA-ubiquitin, and Flag-14-3-3σ plasmids. Cells were treated with MG132
before harvesting. Poly-ubiquitination of p53 was detected by immunoprecipitation with
anti-p53 and immunoblotted with anti-ubiquitin. Lysates were also immunoblotted with
indicated antibodies.

78

Figure 3-33. 14-3-3σ impairs COP1-mediated p53 transcriptional repression
determined by quantitative RT-PCR in cells. The mRNA levels of the indicated p53
target genes, including CDKN1A, SFN, PUMA, and BAX, were detected by RT- PCR in
indicated cells stably expressing vector, Myc-COP1, or RFP-COP1. Some cells were also
infected with the indicated adenovirus expressing β-gal (control) or 14-3-3σ. The expression
levels of the indicated p53 target genes were quantitated, and the data are presented as a heat
map.
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Figure 3-34. 14-3-3σ antagonizes COP1-suppressed p53 transcriptional activity. The
BDS2-3X-luc reporter containing a p53-responsive element was transfected with the
indicated p53, Flag-14-3-3σ, and Flag-COP1 plasmids. Relative luciferase activity was
shown in a bar graph.
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3.10 14-3-3σ inhibits COP1-mediated cell proliferation and transformation
Given that COP1 degrades p53(Dornan et al., 2004b), a tumor suppressor, it is possible that
COP1 has a negative impact on cell cycle arrest. To prove this possibility, cell growth of
COP1 overexpression cells was measured using a MTT assay. We found that stably
expressing COP1 promoted cell growth. However, COP1 overexpression cells infected with
Ad-14-3-3σ reduced cell growth compared with cells infected with Ad-β-gal (Figure 3-35).

It has been reported that the knockdown of COP1 sensitizes p53-induced cell death
following IR treatment (Dornan et al., 2004b). We examined whether 14-3-3σ may sensitize
COP1 overexpressing cells to IR-induced cell death. We found that cell death were
increased when cells were infected with Ad-14-3-3σ compared with cells infected with Adβ-gal in response to IR (Figure 3-36). It indicates that 14-3-3σ facilitates IR-mediated cell
death in COP1 overexpressing cells.

Furthermore we studied cell cycle distribution using flow cytometry. We found that COP1
overexpression cells caused S-phase accumulation (28%), while S-phase was reduced to
18% in HCT116 vector controls. Interestingly, the percentage of 14-3-3σ-infected cells in
G2 phase was higher than cells infected Ad-β-gal (Figure 3-37). It indicates that 14-3-3σ
inhibits COP1-mediated cell proliferation through G2 arrest.

Since that COP1 promotes cell growth, we address whether COP1 promotes cell
transformation. We found that more numbers of colonies in COP1-overexpressing cells than
in control cells using the foci formation assay. However, Ad-14-3-3σ-infected cells reduced
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the numbers of colonies compared with Ad-β-gal-infected cells (Figure 3-38A). We
obtained similar results to confirm COP1 has anchorage-independent growth abilities using
soft agar formation assay. However, Ad-14-3-3σ-infected cells reduced the numbers of soft
agar colonies compared with Ad-β-gal-infected cells (Figure 3-38B). Together, these
functional assays have indicated that COP1 promotes cell proliferation and transformation,
and 14-3-3σ abolishes COP1-promoted cell proliferation and transformation.
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Figure 3-35. 14-3-3σ inhibits COP1-mediated cell proliferation. The number of live cells
of HCT116/Myc-COP1 and HCT116/vector cells was estimated by MTT assay every day
for a total of 7 days (top). The results were expressed as the value of OD570 reading. MycCOP1 expressing cells were infected with Ad-β-gal or Ad-14-3-3σ (bottom). OD570
absorbance of each group was shown. Error bars represent 95% confidence intervals.
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Figure 3-36. 14-3-3σ can sensitize COP1-expressing HCT116 cells to IR-mediated cell
death. HCT116/Myc-COP1 cells were infected with Ad-β-gal or Ad-14-3-3σ on day 1.
Infected cells were treated with or without 10 Gy IR on day 2. Live cells were detected as
dye-excluding cells and counted after trypan blue staining on day 4. The bar graph shows
the percentage of live cells. Error bars represent 95% confidence intervals.
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Figure 3-37. 14-3-3σ inhibits COP1-accumulated S phase population. HCT116/MycCOP1 and HCT116/vector cells were analyzed for cell cycle distribution using FACS (top).
HCT116/Myc-COP1 cells were left uninfected or infected with Ad-β-gal or Ad-HA-14-3-3σ
followed by FACS for cell cycle analysis (bottom). Percentage of each cell cycle phase was
indicated. This experiment was done in triplicate.
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Figure 3-38. 14-3-3σ antagonizes COP1-mediated foci formation. HCT116/Myc- COP1
and HCT116/vector cells were analyzed for foci formation (top, left panel). HCT116/MycCOP1 cells infected with Ad-β-gal or Ad-HA-14-3-3σ were subjected to foci formation
(top, right panel). The foci numbers of vector control cells, COP1 overexpression cells, and
Ad-β-gal-, and Ad-14-3-3σ-infected COP1 overexpression cells are presented as bar graphs
(bottom). Error bars represent 95% confidence intervals.
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Figure 3-39. 14-3-3σ antagonizes COP1-promoted soft agar colony formation.
HCT116/Myc-COP1 and HCT116/vector cells were analyzed by soft agar assay (top, left
panel). HCT116/Myc-COP1 cells infected with Ad-β-gal or Ad-HA-14-3-3σ were subjected
to soft agar assay (top, right panel). The average number of colonies per plate is scored and
represented (bottom). Error bars represent 95% confidence intervals.
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3.11 14-3-3σ inhibits COP1-mediated tumor progression
To confirm that 14-3-3σ blocks COP1 activity in vivo, we used a nude mice xenograft
model to study the roles of COP1 in tumor progression. Myc-COP1-expressing cells and
vector control HCT116 cells were injected into the flanks of nude mice. We found the
tumors grew faster in COP1 expressing groups than in vector control groups (Figure 3-40).
When mice were scarified and xenografts were measured at the end of experiments, we
found that the average of tumor weight and size in COP1 expressing groups was greater than
in than HCT116 control cells (Figure 3-40). This indicates that COP1-expressing cells
formed the larger tumors than vector control HCT116 cells.

Given that the above results, it is interesting to study whether 14-3-3σ abolishes COP1
activity in tumor progression. Ad-14-3-3σ- and Ad-β-gal-infected COP1-expressing cells
were injected in nude mice. We found that tumors grew slower in Ad-14-3-3σ-infected
groups than Ad-β-gal groups (Figure 3-41). The average of tumor weight and size in Ad-143-3σ infected groups is smaller than in Ad-β-gal infected groups (Figure 3-41). Xenografts
removed from mice were prepared for immunohistochemistry. The levels of cleaved caspase
3, a marker for apoptosis, and p53 were higher and the levels of Ki67, a marker for
proliferation, were lower in Ad-14-3-3σ infected groups than in Ad-β-gal groups (Figure 342). Taken together, COP1 overexpression facilitates tumor formation and increases tumor
size while 14-3-3σ compromises COP1-mediated tumor progression.
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Figure 3-40. Overexpression of COP1 promotes tumor progression. Myc-COP1
overexpressing HCT116 stable transfectants and vector control transfectants were injected
subcutaneously into the flank regions of female nude mice. Each group included five mice.
Tumor volumes were monitored for 40 days (top). Tumor growth curves are measured at the
indicated time points. Error bars represent 95% confidence intervals. Tumors were
dissected, and weighed (bar graph) 40 days post-injection (bottom, left panel). Error bars
represent 95% confidence intervals. The photograph shows the size of representative tumors
obtained (bottom, right panel).
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Figure 3-41. 14-3-3σ suppresses COP1-mediated tumor progression. Myc-COP1
overexpressing HCT116 stable transfectants were infected with Ad-14-3-3σ and Ad-β-gal.
Cells were injected subcutaneously into nude mice. Each group included five mice. Tumor
growth curves (top), tumor weight (bottom, left panel), and tumor size (bottom, right panel)
were measured. The error bars show 95% confidence.
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Figure 3-42. Serial tumor sections stained with anti-cleaved Caspase 3 and anti-p53
from experiments in Figure 3-41. Percentage of cells with positive signals from each
staining was quantitated and presented as a bar graph. Error bars represent 95% confidence
intervals.
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Figure 3-43. Serial tumor sections stained with anti-Ki67 from experiments in Figure
3-41. Percentage of cells with positive signals from each staining was quantitated and
presented as a bar graph. Error bars represent 95% confidence intervals.
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3.12 The expression of COP1 and 14-3-3σ has an inverse relationship
Our findings show that the 14-3-3σ inhibits COP1-mediated cell proliferation, cell
transformation, and tumor progression. Using immunoblotting assay, we analyzed protein
levels of 14-3-3σ and COP1 in 24 human primary breast cancer specimens. We found that
the expression of 14-3-3σ and COP1 is disproportional (Figure 3-44). Furthermore, we
examine 121 human pancreatic cancer specimens to study the inverse relationship between
14-3-3σ and COP1 using immunohistochemistry (Figure 3-45). Indeed, low 14-3-3σ
expression was detected in 40 (72.2%) of the 55 pancreatic cancer specimens with high
COP1 expression (p < 0.005) (Table 3-1). Taken together, we have shown that 14-3-3σ and
COP1 have an inverse relationship in breast and pancreatic cancer specimens. This suggests
that 14-3-3σ’s negative impact on COP1 may be clinically useful in the future.
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Figure 3-44. 14-3-3σ and COP1 expression levels are inversely correlated in malignant
human breast cancer specimens. Protein levels of COP1 and 14-3-3σ were analyzed by
immunoblotting (top and middle panel). The integrated optical intensity of COP1 was
plotted against that of 14-3-3σ (bottom panel). Spearman rank order correlation was used to
demonstrate the inverse correlation between COP1 and 14-3-3σ protein levels (p < 0.01).
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Table 3-1. An inverse correlation between 14-3-3σ and COP1 in pancreatic cancer
samples
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Figure 3-45. There is an inverse correlation between 14-3-3σ and COP1 in human
primary pancreatic cancer specimens. Consecutive tissue sections from tumor case I show
a low level of 14-3-3σ but a high level of COP1. In contrast, consecutive sections from
tumor case II show abundant 14-3-3σ but scanty COP1 (Original magnification, 200×). See
Table 3-1 for a summary of expression levels of 14-3-3σ and COP1 expression in these
pancreatic carcinoma samples.
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CHAPTER 4. Discussion

4-1. The functions of COP1 determined by binding of COP1-interacting proteins on
regions of COP1
14-3-3σ directly binds to COP1 and binds to coiled-coil domain of COP1 using the domain
mapping experiment. This binding region is different from other COP1-binding targets such
as FOXO1 and c-JUN (Kato et al., 2008; Wertz et al., 2004). These two proteins bind to
COP1 within WD-40 repeats. Both of them are degraded by COP1. The domain of WD40
repeats is known for protein-protein interacting regions. Importantly, WD40 repeat
containing proteins also have been associated with a diversity of cellular function due to
their targets. For example E3 ligase COP1 binds to its substrate FOXO1 within COP1
WD40 repeats suggests that COP1 facilities FOXO1 degradation and thus inhibits
transcriptional activity. Major targets of FOXO1, such as PEPCK and G6Pase (Kato et al.,
2008), are critical for glucose production. It indicates that COP1 inhibits glucose production
via FOXO1. Taken together, E3 ligase targets of COP1 preferentially bind to its WD40
regions and the interaction provides E3 ligase COP1 for the diversity of function.

In contrast, 14-3-3σ binds to the coiled-coil domain of COP1 in this study. In this case, 143-3σ is not an E3 ligase substrate of COP1. Coiled-coil domain is known for protein-protein
interaction domain and dimerization domain. Indeed, it has been shown that COP1 forms
dimerization through its coiled-coil region (Bianchi et al., 2003). However, it is unknown
why COP1 forms dimers and whether dimerization of COP1 affects COP1 functions. Our
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data suggest that 14-3-3σ may directly affect self-association of COP1 or have an indirect
effect on COP1 self-association through binding to COP1 binding partners. Once COP1
dimerization is abolished, COP1’s activity and function may be abrogated. This will be
further determined.

4-2. Regulation of COP1 stability in unstressed cells
Mammalian COP1 is mainly localized in the nucleus and regulates targets through
proteasome-mediated degradation (Dornan et al., 2006; Dornan et al., 2004b). However,
little is known about the detail regulation in COP1 stability and degradation process. Here
we have shown that the loss of COP1 is rescued following proteasome inhibitor treatment. It
implies that COP1 degradation is mediated by a 26-proteasome pathway. In addition, it is
well known that 14-3-3σ binds to and regulates targets’ stability. In these studies, 14-3-3σ
negatively regulates COP1 through direct interaction with COP1. Furthermore, the turnover
rate of COP1 in the absence of 14-3-3σ is comprised compared to the presence of 14-3-3σ,
suggesting that 14-3-3σ may be involved in the degradation process of COP1. We thereby
discover that 14-3-3σ promotes COP1 ubiquitination in vivo and even in vitro. It is possible
that 14-3-3σ directly regulates COP1 self-ubiquitination. We confirm this regulation in
vitro. However 14-3-3σ is not an E3 ligase and 14-3-3σ’s major function is as an adaptor in
cells. One explanation for 14-3-3σ-facilitated COP1 ubiquitination in vitro is that 14-3-3σ
homo-dimer alters the structure of COP1 and exposes the RING-finger of COP1. This
structure of COP1 is unstable and is easily got degraded through self-ubiquitination. The
stability and turnover rate of COP1 RING mutant should be addressed in the future.
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In vivo 14-3-3σ may indirectly bind to COP1’s negative regulators that ubiquitinate COP1.
For example COP1 binds to MDM2 (data not shown) and 14-3-3σ binds to MDM2 (Yang et
al., 2007)., since it is possible that COP1 is ubiquitinated by MDM2 and 14-3-3σ facilitates
this process. Therefore, characterizing binding partners of COP1 in 14-3-3σ-COP1
complexes will confirm the models between COP1 self-ubiquitination and an E3 ligasemediated COP1 ubiquitination. Taken together, 14-3-3σ downregulates COP1, thus
preventing COP1-mediated p53 degradation, and maintains the basal levels of p53.

4-3. COP1 is 14-3-3σ phosphorylation binding protein
The identification of COP1 domains for 14-3-3σ binding shows that 14-3-3σ preferentially
binds to middle part of COP1 (216 aa – 420 aa) which including coiled-coil domain. It is
well known that the members of the 14-3-3 family show consensus binding motif,
RSXpSXP and RXXXpSXP, on its targets. For this reason, we searched for COP1 sequence
using Netphos2.0 program and identified several sites within coiled-coil region of COP1,
which is potential for 14-3-3σ binding. It includes Ser 387, Ser 404, Ser 332, and Thr 311.
Thus, I screened all of the COP1 mutants’ binding affinity for 14-3-3σ by mutating either
serine or threonine to alanine in vivo (data not shown). Interestingly, we found that 14-3-3σ
no longer binds to COP1 (S387A). It suggests that 14-3-3σ’s binding to COP1 is
phosphorylation-dependent. It has been shown that ATM phosphorylates COP1-Ser 387 in
response to DNA damage. We also confirm that 14-3-3σ-COP1 binding is abrogated in
ATM null cells after DNA damage. Also, it is interesting to identify kinases for the other
potential phosphorylation sites, such as EDST311VP, TEYS332QP, RYNS404VR, and study
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whether these phosphorylation sites are required for 14-3-3σ binding. 14-3-3 targets can be
phosphorylated by different kinases, such as AKT, PKC and CHK1. These phosphorylation
sites suggest that these kinases may compete with each other in regulating COP1 stability.
For example ATM-phosphorylated COP1 leads to COP1 self-ubiquitination while AKT may
phosphorylate COP1 and mask the phosphorylation site, which is phosphorylated by ATM.
Thus AKT-phosphorylated COP1 may lead to COP1 stabilization and COP1 may further
trigger cell survival following AKT signaling. These will be further addressed in the future.

4-4. The stability of COP1 in response to DNA damage
It has been demonstrated that DNA damage triggers ATM-phosphorylated COP1 at Ser 387
which in turn promotes COP1 nuclear export and triggers COP1 ubiquitination (Dornan et
al., 2006). However, it is unclear regarding the mechanism behind COP1 nuclear export
following DNA damage. 14-3-3σ’s binding to COP1 is phosphorylation-dependent in
response to DNA damage in our data. It seems that 14-3-3σ binds to phosphorylated COP1
and thus is involved in nuclear export of COP1. Importantly, we found that 14-3-3σ
promotes the ubiquitination of COP1 that is Ser 387 phosphorylation dependent. In addition,
14-3-3σ -mediated COP1 translocation to the cytoplasm leads to enhanced cytoplasmic
COP1 ubiquitination after DNA damage here. Here we fill the gap that 14-3-3σ is involved
in ATM-mediated COP1 nuclear export and ubiquitination. Given that 14-3-3σ plays a in
COP1 ubiquitination, it will be interesting to explore whether 14-3-3σ-mediated COP1
ubiquitination is through lysine 48 linkage or lysine 63 linkage.
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It was reported that ATM interacts to CSN and phosphorylates CSN3 following DNA
damage. CSN is an upstream effector of COP in plant. Furthermore, a recent report shows
that CSN3 facilitates COP1 downregulation and p53 accumulation after UV irradiation in
mammal. Thus it is tempting to speculate that CSN3 may be involved in ATM-triggered
COP1 instability after DNA damage. In contrast, CSN6 binds to and stabilizes COP1 in our
lab. CSN3 and CSN6 are subunits in COP9 signalosome and show opposite effects on COP1
regulation. CSN6 and CSN3 have different subdomains and they may assemble to different
subunits in complex of COP9 signalosome. It will be interesting to further explore the roles
of COP9 signalosome on COP1 regulations in mammals.

4-5. 14-3-3σ is downregulating COP1 and inhibits COP1-mediated cell cycle
progression
14-3-3σ, a p53 target gene, is induced in response to DNA damage. The induction of 14-33σ by the DNA damage causes G2 arrest, indicating 14-3-3σ is a negative regulator of cell
cycle progression. 14-3-3σ negatively regulates proteins that target cell cycle progression.
For example, 14-3-3σ binds to cyclin-dependnt kinases and blocks the activity of CDKs
(Chan et al., 1999; Laronga et al., 2000), thereby inhibiting cell growth. Moreover, 14-3-3σ
regulates the stability of oncogenic proteins and leads to the stability of p53. For example,
14-3-3σ facilitates the turnover rate of MDM2, thereby leading to prevent MDM2-mediated
p53 degradation (Yang et al., 2003). Therefore, it is possible that 14-3-3σ may regulate cell
cycle negative regulator COP1 due to the involvement of p53 degradation. Eventually 14-33σ-COP1 regulations lead to the proper cell cycle process. Our data show that DNA
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damage-induced 14-3-3σ caused COP1 downregulation. In addition, cells overexpressing
COP1 lead to cell proliferation and S-phase accumulation while ectopic 14-3-3σ inhibits
COP1-mediated cell proliferation through G2 arrest. So far it is unknown about the role of
COP1 in cell cycle regulation. The level of COP1 during cell cycle is the first thing that
should be addressed. This mechanistic study will help understand how 14-3-3σ negatively
regulates COP1 during cell cycle.

4-6. 14-3-3σ plays an important role in protecting p53 from E3 ligase
p53 has three major RING-containing E3 ligases, such as COP1, MDM2, and Pirh2. In
normal conditions, p53 levels are tightly controlled by these E3 ligases. In our previous
study, we show that14-3-3σ stabilizes p53 through shortening the turnover rate of MDM2
and facilitating the ubiquitination of MDM2. In this study, we also found that 14-3-3σ
inhibits COP1-mediated p53 ubiquitination and transcriptional repression. It is possible that
14-3-3σ-COP1 axis regulates p53 via 14-3-3σ-MDM2 pathway. Our results show that 14-33σ blocks COP1-mediated p53 ubiquitination, and this process is independent of MDM2
although we detect that COP1 binds to MDM2. Moreover, 14-3-3σ inhibits COP1-mediated
p53 nuclear export regardless of MDM2 (data not shown). Therefore MDM2 binding to
COP1 is not required for COP1 negative effects on p53. We conclude that 14-3-3σ blocks
COP1-mediated p53 instability, and this process is independent on 14-3-3σ’s negative
impacts on MDM2.
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In Figure 3-3, we found that p53 levels are not reduced in 14-3-3σ null cells compared to
14-3-3σ wild-type cells upon doxorubicin treatment. It is not what we expected because 143-3σ has a positive feedback on p53 as we mention. We will further confirm this issue by
using different cell lines and different DNA damage agent.

4-7. Roles of COP1 in chromosome stability
COP1 overexpression was found in ovarian and breast cancer, indicating that COP1 plays an
important role in tumorigenesis. Notably, we found that COP1 overexpression in HCT116
leads to chromosome breaks and fusion, leading to γ-H2AX accumulation (data not shown).
It indicates that COP1 overexpression causes a lot of genomic instability. It is interesting to
further examine that overexpression of COP1 may either induce checkpoint defects,
chromosome aberration, or DNA repair defect, thus promoting tumor progression. One of
the possibilities is that COP1 overexpression leads to p53 ubiquitination. The lack of
functional p53 pathway leads to the failure of proper G1 checkpoint and centrosome
aberrations. There are several examples showing that overexpression of cyclin E contributes
to genomic instability through the defect cell cycle checkpoint (Spruck et al., 1999) and
overexpression of MDM2 leads to chromosome breaks through binding to Nbs1, thus
abolishing the function of Mre11–Rad50–Nbs1 in DNA repair signaling (Alt et al., 2005;
Bouska et al., 2008). We found that homologous recombination was reduced in COP1overexpressing cells (data not shown). It is a piece of strong evidence that COP1 negatively
regulates homologous recombination repair. At the same time, we should hypothesize
whether COP1 plays a role in DNA repair signaling. Logically COP1 may delay the
accumulation of DNA repair protein at double strand breaks or ubiquitinate DNA repair
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factors, thereby causing chromosome abnormality and tumor pregression. We will further
study the mechanism by which COP1 inhibits the DNA repair signaling in the future.

4-8. 14-3-3σ impacts on an oncoprotein COP1
The oncogenic activities of COP1 are attributed to ubiquitinate p53 and inhibit p53dependent apoptosis. In addition, COP1 is overexpressed in ovarian and breast
adenocarcinomas. In our study, we also found that COP1 is deregulated in pancreatic and
breast cancer patient samples. Taken together, it indicates that COP1 may have oncogenic
activities and promote tumor progression. However, it remains a question how COP1
executes its oncogenic activities. We showed that COP1 overexpression leads to increased
cell proliferation, S-phase accumulation, cell transformation and tumor progression. It has
been shown that 14-3-3σ suppressed the anchorage-independent growth of some breast
cancer cell lines and reduced 14-3-3σ expression in head and neck squamous and
keratinocytes. We hypothesize that 14-3-3σ has its tumor suppressor function to block
COP1’s oncogenic effect. The result that 14-3-3σ abrogates COP1 cell proliferation, cell
transformation, and tumor progression supports an idea that 14-3-3σ is one of the
mechanism to eliminate COP1 oncogenic activity. At the same time, COP1 is overexpressed
in high percentage of pancreatic cancer samples in which 14-3-3σ expression is low in our
clinical samples. Moreover, breast cancer samples demonstrate expressing COP1 and 14-33σ has the inverse correlation. Therefore 14-3-3σ can be developed as a clinical therapeutic
target treating COP1-overexpresison cancer patients in the future.

4-9. Possible COP1 upstream positive regulators/kinases
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COP1 E3 ligase degrades tumor suppressors including p53 and FOXO1. Here we discovered
that COP1 overexpression leads to cell proliferation and tumor progression. Thus it is
tempting to address the upstream signals that regulate stability of COP1 and trigger COP1
oncogenic activities. Scanning the COP1 sequence, COP1 contain a lot of serine and
threonine residues, suggesting that COP1 is phosphorylated by theronine/serine kinases.
These kinases, including AKT, CDK2, PKC, and Pim family, can promote cell growth and
survival (Ellwood-Yen et al., 2003; Hammerman et al., 2005; Zippo et al., 2007). For
example, Pim-1 has been reported to phosphorylate and stabilize Skp2, thereby leading to
Skp2-mediated p27 degradation (Cen et al.2010; Gao et al., 2009; Rodier et al., 2008).
Lower p27 levels lead to deregulation in cell cycle. However none of the kinases are found
to regulate COP1 activities. The COP1 sequence is analyzed for identifying these kinasephosphorylated consensus site. Importantly, we found that COP1 contain a potential AKT
and Pim-1 phosphorylated consensus site. We will further examine whether COP1 is
regulated by AKT and Pim-1, and if they regulate COP1 stability. Therefore, kinases
interplay between AKT and ATM may determine the activities of COP1 and affect the cell
fate.

4-10. Future directions
To observe the role of COP1 in cell growth, I have generated COP1 overexpression cells. In
addition to cell proliferation in COP1 overexpression cells, I accidentally found that more γH2AX was detected in COP1 overexpression cells compared to vector control cells. It
indicates that COP1 expression enhances DNA double strand breaks. Moreover, more
chromosome aberrations were found in COP1 overexpression cells using karyotyping
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analysis. It indicates that COP1 overexpression causes the accumulation of DNA double
strand breaks, which in turn leads to chromosome instability. If it is true, we can explain that
COP1-induced DNA damage causes chromosome aberrations, thereby leading to
tumorigenesis. However it is unclear how COP1 negatively regulates DNA repair signaling.
Here the preliminary data shows that homologous recombination repair process is inhibited
in COP1 overexpression cells after I-SceI-induced double strand breaks. Moreover COP1
expression cells sensitize to IR-induced cell death using cell survival foci formation assay.
Technically in addition to the accumulation of DNA damage defect in COP1 overexpression
cells, it should be further confirmed that defective DNA repair is reduced in COP1
knockdown cells. Taken together, COP1 may play a role in homologous recombination
repair. I hypothesize that COP1 causes defective DNA repair due to the inhibition of
homologous recombination repair. Therefore I propose two specific aims for the future
study.

(1) To determine whether AKT phosphorylates cytoplasmic COP1 and phosphorylated
COP1 translocates to the nucleus upon DNA damage.
Our preliminary data have shown that AKT interacts with COP1 and translocates COP1 to
the nucleus. We further address whether COP1 is a substrate of AKT and AKT
phosphorylates COP1, thereby translocating phosphorylated COP1 to the nucleus upon
DNA damage. It will further distinguish that COP1 shuttling is contributed by ATM and
AKT upon DNA damage.
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(2) To determine whether COP1 regulates DNA damage and repair proteins following
DNA damage.
Given that DNA damage signal regulates COP1 (Dornan et al., 2006), it is unknown whether
AKT-phosphorylated COP1 is localized at DNA double strand breaks. To observe whether
COP1 is accumulated at ionizing radiation-induced foci formation (IRIF), the interactions
between COP1 and γH2AX need to be addressed using co-immunoprecipitation and live-cell
image assays. If COP1 is localized at the foci, I will further investigate whether COP1
abrogates downstream proteins accumulation in IRIF. COP1-knockdown cells and COP1knockdown cells reconstituted with wild-type COP1 can be addressed in DNA damageinduced foci, including MDC1, RNF8, and 53BP1 foci etc. If COP1 knockdown causes the
accumulation of MDC1, RNF8, and 53BP1 foci, the mechanism behind COP1’s negative
impacts on DNA repair proteins will be further identified.

(3) To determine whether COP1 regulates DNA damage and repair proteins following
DNA damage.
Given that MDC1 and 53BP1 contain COP1 consensus binding motif, it is tempting to
further address whether COP1 negatively regulates MDC1 and 53BP1 in response to DNA
damage.

Taken together, COP1 is overexpressed in ovarian and breast cancer. However, how COP1
causes tumor progression is poorly understood in addition to degrade functional p53
proteins. Studying whether COP1 causes defective DNA and reduce DNA repair process
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and in turn too many damage DNA lead to cancer formation will help the designation of
therapeutic agents that target on COP1.

In summary, 14-3-3σ is induced by p53 transcriptional factor following DNA damage and
14-3-3σ is shown to positively regulate p53. COP1 is an E3 ligase for p53. Following DNA
damage, COP1 is phosphorylated by ATM and translocated to the cytoplasm. However, the
mechanism of COP1 translocation to the cytoplasm is still unclear. Here the study shows
that doxorubicin-induced DNA damage causes COP1 downregulation, which is dependent
on 14-3-3σ. However 14-3-3σ only reduces protein levels not mRNA levels of COP1,
indicating that 14-3-3σ negatively regulates COP1 through post-translational modification,
such as ubiquitination and phosphorylation. To further address specific roles of 14-3-3σ on
the levels of COP1, we found that 14-3-3σ decreases the steady-state levels of COP1,
facilitates the turnover rate of COP1, and promotes ubiquitination of COP1. This indicates
that 14-3-3σ negatively regulates COP1 through facilitating COP1 ubiquitinating process.
To examine the mechanism which 14-3-3σ negatively regulates COP1, we identify that 143-3σ functions as an adaptor and binds to phosphorylated COP1 at Ser 387 after DNA
damage, thereby leading to the nuclear export of COP1. Cytoplasmic COP1 ubiquitination is
increased in the presence of 14-3-3σ compared to those in the absence of 14-3-3σ. In
contrast, COP1 (S387A) loses the binding site for 14-3-3σ. In turn, 14-3-3σ loses the ability
to promote the nuclear export, the turnover rate and ubiquitination of S387A mutant (Figure
4-1). Importantly, to study biological significance of 14-3-3σ’s negative impact on COP1mediated p53 instability, we have shown that 14-3-3σ blocks COP1-mediated p53
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degradation, and COP1-suppressed p53 transcriptional activity. Furthermore, 14-3-3σ
abolishes COP1-promoted cell growth, cell transformation, and tumor progression. Taken
together, 14-3-3σ can be developed as a clinical therapy treat COP1-overexpresison cancer
patients in the future.
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Figure 4-1. Working model. Once DNA damage occurs and ATM is activated, ATM phosphorylates
COP1 at Ser 387. This phosphorylation event enables 14-3-3σ to recognize and bind to COP1, resulting
in COP1 translocation to the cytoplasm, and COP1 ubiquitination, and in turn the stabilization of p53
(top). 14-3-3σ blocks COP1-miedated cell proliferation, cell transformation, and tumor progression. In
addition, 14-3-3σ protects p53 from COP1-miedated p53 degradation and p53 transcriptional repression
(bottom).
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